CN111808836B - Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof - Google Patents

Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof Download PDF

Info

Publication number
CN111808836B
CN111808836B CN202010715201.5A CN202010715201A CN111808836B CN 111808836 B CN111808836 B CN 111808836B CN 202010715201 A CN202010715201 A CN 202010715201A CN 111808836 B CN111808836 B CN 111808836B
Authority
CN
China
Prior art keywords
lys
val
asp
gly
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010715201.5A
Other languages
Chinese (zh)
Other versions
CN111808836A (en
Inventor
逄晓阳
吕加平
杨洋
芦晶
张书文
李伟勋
朱青
徐琛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Food Science and Technology of CAAS
Original Assignee
Institute of Food Science and Technology of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Food Science and Technology of CAAS filed Critical Institute of Food Science and Technology of CAAS
Priority to CN202010715201.5A priority Critical patent/CN111808836B/en
Publication of CN111808836A publication Critical patent/CN111808836A/en
Application granted granted Critical
Publication of CN111808836B publication Critical patent/CN111808836B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2451Glucanases acting on alpha-1,6-glucosidic bonds
    • C12N9/2457Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/16Preparation of compounds containing saccharide radicals produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01041Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a heat-resistant mutant enzyme of pullulanase I, the amino acid sequence of which is shown as SEQ ID No.1, or SEQ ID No.2, or SEQ ID No.3, or SEQ ID No.4, or SEQ ID No. 5. The invention also discloses a gene for coding the mutant enzyme, which is shown as SEQ ID No.6, or SEQ ID No.7, or SEQ ID No.8, or SEQ ID No.9, or SEQ ID No. 10. The invention also discloses a preparation method of the mutant enzyme, which comprises the steps of selecting a mutation site from the amino acid sequence of the pullulanase and designing a mutation primer pair; carrying out point mutation reaction by taking a vector carrying a pullulanase gene as a template to obtain a mutant plasmid; then replicating and expressing in the transformation engineering bacteria. The mutant enzyme of the invention has better heat resistance.

Description

Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof
Technical Field
The present invention relates to the technical field of genetic engineering and enzyme engineering. More specifically, the invention relates to a heat-resistant mutant enzyme of pullulanase I and a preparation method and application thereof.
Background
Many pullulanases have been discovered at present, and even pullulanases have been studied at the genetic level. However, there are few pullulanases that can be used in industrial production, and pullulanase derived from Bacillus acidopululyticus is currently most commercialized. The main application mode of the pullulanase is used in the saccharification process of starch, the industrial application condition is that the pH is 4.5-5.5, the temperature is 55-65 ℃ or even higher, and the sustained action time is up to 48-60 h (NISHA and SATYANARAYANA, 2016). Most of the reported pullulanase type I cannot adapt to the industrial condition, some enzymes have poor heat resistance, and some enzymes have low or even inactivated enzyme activity under the condition of pH5.5 or lower. Even commercial b.acetidopululilyticus pullulanase presents a significantly shorter plate with a half-life of only 34.9min at 60 ℃, without sufficiently strong thermostability.
In view of the above situation, the present invention is to provide pullulanase having high heat resistance, taking the heat resistance of pullulanase as a primary consideration. The heat-resistant pullulanase is mostly derived from thermophilic or extreme thermophilic microorganisms, and the growth conditions and the culture conditions are severe, so that the sampling and screening are not facilitated. Therefore, it is worth trying to obtain pullulanase with good heat resistance by adopting a genetic engineering technical mode.
Disclosure of Invention
An object of the present invention is to solve at least the above problems and to provide at least the advantages described later.
Still another object of the present invention is to provide a heat-resistant pullulanase type I mutant enzyme having excellent heat-resistant properties, and a method for preparing the same.
To achieve these objects and other advantages in accordance with the present invention, there is provided a mutant enzyme of heat-resistant pullulanase type I having an amino acid sequence shown in SEQ ID No.1, or shown in SEQ ID No.2, or shown in SEQ ID No.3, or shown in SEQ ID No.4, or shown in SEQ ID No. 5.
Provides a gene for coding the mutant enzyme, and the nucleotide sequence of the gene for coding the mutant enzyme is shown as SEQ ID No.6, or shown as SEQ ID No.7, or shown as SEQ ID No.8, or shown as SEQ ID No.9, or shown as SEQ ID No. 10.
An engineered bacterium comprising a gene encoding the mutant enzyme is provided.
There is provided a vector comprising a gene encoding the above mutant enzyme.
There is provided a method of preparing the mutant enzyme, comprising the steps of:
step one, performing homologous modeling according to an amino acid sequence of the pullulanase type I disclosed in an NCBI database, selecting amino acid residues within 10 angstroms from catalytic sites of the pullulanase type I as objects based on sequence alignment analysis and protein structure analysis, excluding very conservative amino acid residues through sequence alignment, selecting 5 non-conservative amino acid mutation sites, designing corresponding mutation primer pairs for the 5 mutation sites, wherein the mutation primer pairs are respectively mutation primer pairs
5'-CGGCGTGGGCAATGTTATCGCGACCGAACGT-3' and
5′-GATAACATTGCCCACGCCGCTTTCATTCAGATACG-3′、
5'-CGTGGGCAATGTTATGGCGAGCGAACGTCCGAT-3' and
5′-CTCGCCATAACATTGCCCACGCCGCTTTCATTC-3′、
5'-CGTCCGATGCTGCGCAAATATATCATTGATACCCTG-3' and
5′-GATATATTTGCGCAGCATCGGACGTTCGGTCGCCAT-3′、
5'-AAAACCATGCTGGACGTGGAAAAAGAACTGC-3' and
5′-CGTCCAGCATGGTTTTTTTATCCATCAGGC-3′、
5'-ATTTTGCGCGCACCAAAAAATTCGATGAGAACAGC-3' and
5′-AATTTTTTGGTGCGCGCAAAATCCTGGCCCGCAT-3′;
secondly, respectively carrying out point mutation reactions by using a vector carrying the type I pullulanase gene as a template and a designed mutation primer pair and utilizing a PCR mutation method to obtain a mutation plasmid with a mutant enzyme gene;
and step three, converting the mutant plasmid obtained in the step two into engineering bacteria capable of expressing target genes, and expressing corresponding mutant enzymes along with the replication of the engineering bacteria.
Preferably, the point mutation reaction conditions in step two are: pre-denaturation at 94 ℃ for 5 min; melting at 94 ℃ for 20s, annealing at 65 ℃ for 20s, and extending at 72 ℃ for 4min for 25 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃.
Preferably, the engineering bacterium in the second step is Escherichia coli.
Preferably, the vector in step two is pET-22b (+).
Preferably, Ni is used2+And (3) separating and purifying the mutant enzyme by an affinity chromatography mode.
Provides an application of the mutant enzyme in preparing products for enzymolysis of polysaccharide containing a-1, 6 glycosidic bonds.
The invention at least comprises the following beneficial effects:
firstly, 5 mutant enzymes with heat resistance superior to that of the existing pullulanase I PulF are obtained.
Secondly, compared with the existing pullulanase PulF, 5 mutant enzymes have higher enzyme activity in a wider pH range, and particularly, the relative enzyme activity of the mutant enzymes is more than 85% in the pH range of 5.0-5.5. Under the condition of pH4.5, the relative enzyme activity of 5 mutant enzymes is obviously higher than that of Pullulan enzyme PulF. Within the pH range of 6.0-7.0, the relative enzyme activity of 5 mutant enzymes is obviously higher than that of Pullulan enzyme PulF.
The relative enzyme activity change trend of the third and 5 mutant enzymes is greatly different from that of Pullulan enzyme PulF, but the 5 mutant enzymes have more consistent trend, the enzyme activity is slowly reduced when the pH value is far away from the optimum value, and the relative enzyme activity is more than 50% in the range of pH 5.0-6.5. And different buffer solution systems have little influence on the enzyme activity of the buffer solutions, and the relative enzyme activity in the phosphate buffer solution with the pH value of 6.0 is closer to that in the acetic acid buffer solution with the pH value of 6.0. Because the pH range of the pullulanase reaction in the sugar industry is 4.5-5.5, the greatest advantages of the 5 mutant enzymes compared with the pullulanase PulF are as follows by combining the analysis of the industrial application condition: the enzyme activity is higher within the range of pH5.0-5.5, and the requirement on the pH environment of reaction liquid in the saccharification process is not harsh.
Fourthly, when pullulanase PulF is mutated into M485I, T487S, V496I, L528V and G688F, the optimum temperature is changed to 75 ℃. Within the range of 60-75 ℃, the relative enzyme activity of 5 mutant enzymes is greater than that of Pullulan enzyme PulF at the temperature.
The pullulanase in the sugar industry has the advantage that the pullulanase has higher relative enzyme activity in the temperature range of 60-75 ℃ by combining the analysis of the industrial application condition because the reaction temperature is 55-65 ℃ or even higher, wherein the most common reaction temperature is 60 ℃.
Fifth, the thermostability of all 5 mutant enzymes was enhanced at 75 ℃ in the order from strong to weak: L528V > G688F > V496I > T487S > M485I; the thermal stability of 5 mutant enzymes is higher than that of Pullulan enzyme at 80 ℃, and the thermal stability of the mutant enzymes is in the order from strong to weak: V496I > G688F > T487S > L528V > M485I. The sequences of the thermal stability of 5 mutant enzymes are different under the two temperature conditions.
At 75 ℃, the half-life of M485I is improved to a minimum, and is improved by nearly 4 times compared with pullulanase PulF. At 80 ℃, the half-lives of all enzymes are very short, wherein the half-life of V496I is the longest, and the half-life of M485I is the shortest.
Sixth, K for 5 mutant enzymes compared to Pullulan enzymemThe values are reduced, which indicates that the combination capability of the mutant enzyme and the pullulan is enhanced; catalytic constants K of mutant enzymes M481I, V496I, L528V and G688Fcat/KmAll are increased, which shows that the catalytic efficiency of the mutant enzymes on the pullulan is improved.
Additional advantages, objects, and features of the invention will be set forth in part in the description which follows and in part will become apparent to those having ordinary skill in the art upon examination of the following or may be learned from practice of the invention.
Drawings
FIG. 1 is a nucleic acid electrophoresis diagram of 5 site-directed mutagenesis PCR products of the present invention;
FIG. 2 is a standard curve of the protein of the present invention;
FIG. 3 is a diagram of denaturing polyacrylamide gel electrophoresis of the purified 5 mutant enzymes of the present invention;
FIG. 4 is a graph showing half-lives at 75 ℃ of 5 mutant enzymes and Pullulan enzyme PulF of the present invention;
FIG. 5 is a graph showing the half-life at 80 ℃ of 5 mutant enzymes of the present invention.
Detailed Description
The present invention is further described in detail below with reference to the attached drawings so that those skilled in the art can implement the invention by referring to the description text.
It is to be noted that the experimental methods described in the following embodiments are all conventional methods unless otherwise specified, and the reagents and materials are commercially available unless otherwise specified.
1. Raw material preparation
Biological material: as shown in Table 1
TABLE 1 biomaterials
Figure BDA0002597920020000041
The method for constructing pET-22b (+) -pulF comprises the following steps:
the accession number and the microbial source of WP-011994577.1 (Fervidobacterium nodosum Rt17-B1) are selected as original enzymes, and the pullulanase is named as PulF for convenience of expression.
After the signal peptide coding sequence of the gene sequence of the pullulanase PulF is removed, the total length of the gene fragment derived from Fervidobacterium nodosum is 2460bp, and the gene of the 2460 total length fragment is synthesized by Huada gene after codon optimization. The synthesized gene sequences were ligated into expression vector pET-22b (+) via NdeI/XhoI double cleavage sites and transformed into competent cells BL21(DE 3). Positive clones were picked from LB plates supplemented with ampicillin (final concentration 100. mu.g/mL) and the successfully sequenced recombinant bacteria were stored in 15% glycerol tubes. The successfully constructed recombinant plasmid was named pET-22b (+) -pulF. The nucleotide sequence of the gene for coding the pullulanase PulF is shown in SEQ ID No.11, the nucleotide sequence of the gene for coding the pullulanase PulF after codon optimization is shown in SEQ ID No.12, and the amino acid sequences of the pullulanase PulF and the pullulanase PulF after codon optimization are the same and are shown in SEQ ID No. 13.
Culture medium:
LB liquid Medium (g/L): tryptone 10, yeast extract powder 5, sodium chloride 10, pH7.0, 121 ℃, sterilized for 15 min.
LB solid Medium (g/L): tryptone 10, yeast extract powder 5, sodium chloride 10, agar powder 20, pH7.0, 121 ℃, sterilized for 15 min.
The main reagents are as follows:
analytically pure reagents such as sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride, imidazole, Ethylene Diamine Tetraacetic Acid (EDTA), glacial acetic acid, sodium acetate, anhydrous glucose, phenol, sodium hydroxide, potassium sodium tartrate, sodium bisulfite, 3, 5-dinitrosalicylic acid, n-butyl alcohol, anhydrous ethanol, concentrated sulfuric acid, chloride salts of various metal ions and the like are purchased from Beijing GmbH (national chemical group of chemical reagents); precast gel (SurePAGE)TMBis-Tris, 8%, 10 well) and SDS-PAGE running buffer purchased from kasei biotechnology limited; SDS-PAGE protein loading buffer and protein marker, purchased from Dalibao bioengineering company; affinity chromatography column packing (Ni)
Figure BDA0002597920020000051
High Performance), available from general electric medical Group (GE) of america; BCA protein quantification kit, plasmid miniprep kit, BL21(DE3) competence and DH5 alpha competence, all purchased from Tiangen Biochemical technology (Beijing) Co., Ltd; fast Mutagenesis System kit, available from TransGen Biotech, Inc., Beijing, all-purpose gold Biotechnology.
Cell disruption buffer (lysine buffer): 50mM phosphate buffer, 100mM sodium chloride, pH 7.0;
loading buffer (Binding buffer): 50mM phosphate buffer, 500mM sodium chloride, pH 7.0;
washing buffer (Washing buffer): 50mM phosphate buffer, 500mM sodium chloride, 100mM imidazole, pH 7.0;
elution buffer (elusion buffer): 50mM phosphate buffer, 500mM sodium chloride, 500mM imidazole, pH 7.0;
dialysate a (dialysate a): 50mM phosphate buffer, 10mM EDTA, pH 7.0;
dialysate b (dialysate b): 50mM phosphate buffer, pH 7.0.
The main apparatus is as follows:
avanti JXN-26 intelligent high efficiency centrifuge, beckmann coulter ltd, usa; ultrasonic cell disruption instrument JY92-IIN, Ningbo Xinzhi Biotech GmbH; a nucleic acid protein detector HD-2 and a constant flow pump HL-2, Shanghai Kaishi Instrument Analyzer; PowerPac Basic and Mini-PROTECTAN Tetra Cell electrophoresis System, Bio-Rad, USA; constant temperature shaking incubator, shanghai-chang scientific instruments ltd; gel imaging system, shanghai volitang scientific instruments ltd; model TP600 PCR Instrument, TaKaRa, Japan;
Figure BDA0002597920020000063
20M multifunctional microplate reader, Tekken company, Switzerland.
2. Experimental methods
2.1 site-directed mutagenesis:
a mutation primer is designed by using pET-22b (+) -PulF as a template, and a gene encoding PulF is subjected to point mutation by using a Fast Mutagenesis System kit. The mutant primer sequences are shown in Table 2, the point mutation reaction system is shown in Table 3, and the reaction conditions of the point mutation PCR are as follows: pre-denaturation at 94 ℃ for 5 min; melting at 94 ℃ for 20s, annealing at 65 ℃ for 20s, and extending at 72 ℃ for 4min for 25 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃.
TABLE 2 mutant primer sequences
Figure BDA0002597920020000061
TABLE 3 Point mutation reaction System
Figure BDA0002597920020000062
Figure BDA0002597920020000071
After the point mutation PCR reaction is finished, 5 mu L of PCR product is taken and subjected to 1% agarose gel electrophoresis detection, if bright and clear target bands appear and the size is consistent with the expected size, the successful amplification is indicated. To the PCR product successfully amplified, 0.5. mu.L of DMT enzyme was added and incubated at 37 ℃ for 1 hour to remove the plasmid template.
2.2 transformation and preservation of PCR products:
after the PCR product is digested by DMT enzyme, DMT competent cells are transformed for replication and verification, and the transformation steps are as follows:
(1) taking out DMT competent cells, slightly thawing, adding 5 μ L of PCR product digested with DMT enzyme under aseptic condition, gently mixing, and ice-cooling for 30 min;
(2) performing heat shock in 42 ℃ water bath for 45s, then rapidly placing competent cells on ice, and standing for 3min, wherein the action needs to be gentle without shaking a centrifuge tube;
(3) adding 500 μ L of SOC culture medium (without antibiotic) at room temperature into each tube of competent cells under sterile condition, and resuscitating at 37 deg.C and 200rpm for 1 h;
(4) under the aseptic condition, the recovered bacterial liquid is blown and beaten uniformly, 200 mu L of the liquid is taken and coated on an LB solid culture medium containing ampicillin, and the liquid is cultured for 12h at 37 ℃;
(5) the colonies were picked and the plasmids were extracted for sequencing.
The plasmid with error-free sequence alignment is the plasmid with successful site-directed mutagenesis, and then E.coli BL21(DE3) competent cells are transformed for subsequent expression. The successfully transformed recombinant bacterium E.coli BL21(DE3) is frozen and stored in a glycerol tube for later use.
2.3 purification of mutant enzymes:
induced expression of mutant enzymes:
and taking out the successfully constructed mutant recombinant bacteria from a glycerol cryopreservation tube, streaking the recombinant bacteria on an LB solid culture medium containing ampicillin, and culturing the recombinant bacteria at 37 ℃ for 12 h. Single colonies were picked and inoculated into 20mL of LB liquid medium (Amp)+100. mu.g/mL) was cultured at 37 ℃ for 10 h at 200rpm to form a seed solution. Seed liquid for treatingInoculating 2% of the inoculum size in LB liquid medium (Amp)+100 μ g/mL, liquid loading 400mL/2L), culturing at 37 ℃ and 200rpm until OD600nm reaches 0.6-0.8. IPTG was added to the medium at a final concentration of 1mM, and the culture was continued at 28 ℃ and 200 rpm. After 6h, the fermentation broth is centrifuged for 15min at 6000rpm and 4 ℃, and thalli are collected.
Separation and purification of mutant enzyme protein:
the cells were resuspended in cell disruption buffer (Lysis buffer) and disrupted by sonication at 150W for 15min under ice bath conditions. Centrifuging at 8000rpm for 20min at 4 deg.C after crushing, filtering the supernatant with 0.22 μm water system filter membrane, and collecting filtrate;
sample the filtrate to Ni2+In the affinity column, the column is previously equilibrated with a loading buffer (Binding buffer). After the filtrate is completely loaded, continuously balancing the column by using a loading buffer solution (Binding buffer) until no protein is detected in the effluent liquid;
washing the column with Washing buffer (Washing buffer) until no protein is detected in the effluent;
eluting the target protein by using an Elution buffer (Elution buffer), and collecting the eluent until the protein cannot be detected in the eluent;
dialyzing the eluent in the dialysate A to remove salt ions and metal ions in the eluent, and dialyzing for 2 times, each time for 2-3 h;
and (4) continuously dialyzing the eluent in the dialysate B to remove the EDTA in the eluent, and dialyzing for 2 times, 2-3 h each time. Collecting the eluent to obtain the purified mutant enzyme solution. For convenience of description, the 5 resulting mutant enzymes were designated as M485I, T487S, V496I, L528V, G688F, respectively. Wherein, the amino acid sequences of the mutant enzymes M485I, T487S, V496I, L528V and G688F are respectively shown as SEQ ID No.1, SEQ ID No.2, SEQ ID No.3, SEQ ID No.4 and SEQ ID No.5, and the nucleotide sequences of the genes for coding the mutant enzymes M485I, T487S, V496I, L528V and G688F are respectively shown as SEQ ID No.6, SEQ ID No.7, SEQ ID No.8, SEQ ID No.9 and SEQ ID No. 10.
The above processes are all carried out at 4 ℃.
Protein content determination of mutant enzymes:
determining the protein concentration of the purified mutant enzyme solution using a BCA protein quantification kit,
denaturing polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the mutant enzymes:
mu.L of 5 Xloading buffer and 20. mu.L of mutant enzyme solution were mixed and boiled for 10 min. Centrifuging to obtain 10 μ L supernatant, loading to 8% prefabricated gel sample well, and running gel at 150V voltage. After running the glue, dyeing with Coomassie brilliant blue R250 for not less than 3 h. Then decolorized until the background is clear and viewed by a gel imaging system.
3. Determination of enzymatic Properties of mutant enzymes
The enzyme activity determination method comprises the following steps:
pullulan polysaccharide with the final concentration of 0.5% (w/v) is used as a substrate, and the mutant enzyme to be detected catalyzes and reacts for 10min under the optimal condition. After the reaction is finished, the content of reducing sugar released during the enzyme reaction is measured by a 3, 5-dinitrosalicylic acid method (DNS method) to indirectly calculate the enzyme activity. The specific experimental steps are as follows: 20 mu L of 1% (w/v) pullulan polysaccharide dissolved in buffer solution with the optimal pH value is preheated for 5min under the optimal temperature condition; adding 20 μ L of diluted enzyme solution into preheated substrate solution rapidly, and reacting at optimum temperature for 10 min; after 10min, 3, 5-dinitrosalicylic acid reagent (DNS reagent) is rapidly added to stop the reaction, the temperature of the mixed solution is raised to 99.9 ℃, and the color development is carried out for 10 min. After the color development is finished, 100 mu L of deionized water is added and mixed fully, 100 mu L of the mixture is added into a 96-hole enzyme label plate, and the absorbance is measured at the wavelength of 540 nm. Definition of enzyme activity (U): under certain reaction conditions, the pullulanase required for releasing 1 mu mol of reducing sugar from the pullulan in unit time (1min) is obtained.
Wherein, the optimal enzyme reaction conditions are as follows: M485I, T487S, V496I, L528V and G688F were all 75 ℃ and pH 5.5.
Influence of pH on enzyme Activity:
under the optimal temperature, 1% (w/v) pullulan dissolved in buffer solutions with different pH values is used as a substrate to determine the enzyme activity. The pH range is 3.5-7.5, and two buffer solution systems are adopted: 0.2M acetate buffer solution with the pH value of 3.5-6.0; 0.2M phosphate buffer solution with pH of 6.0-7.5. The enzyme activities measured under different pH conditions are expressed by relative enzyme activities, and the measured highest enzyme activity is 100%.
Wherein, the optimum reaction temperature of the enzyme is as follows: M485I, T487S, V496I, L528V and G688F were all 75 ℃.
Influence of temperature on enzyme activity:
taking 1% (w/v) pullulan dissolved in buffer solution with the optimal pH as a substrate, and determining the enzyme activity of the mutant enzyme at different temperatures (4-90 ℃). The enzyme activities measured at different temperatures are expressed by relative enzyme activities, and the measured highest enzyme activity is 100%.
Wherein, the optimum reaction pH of the enzyme is as follows: M485I, T487S, V496I, L528V and G688F were all pH 5.5.
Effect of temperature on enzyme stability:
adding pullulanase solution into the buffer solution with the optimal pH value according to the volume ratio of 1:1, incubating at different temperatures, and sampling at intervals to measure the enzyme activity. The residual enzyme activity was calculated with the initial enzyme activity of the enzyme solution without incubation as 100%.
Determination of enzyme kinetic parameters:
preparing a pullulan series solution with the concentration range of 0.5-1.0 mg/mL and dissolved in a buffer solution with the optimal pH value, and using the solution to determine the enzyme kinetic parameters of pullulanase. Except for different pullulan concentrations, the enzyme activity of the enzyme under the series of substrate concentrations is determined under the standard condition, and K is calculated by a Mie equation (Linweaver-Burk equation)mAnd VmaxValue, and then K is calculatedcatAnd Kcat/KmThe value is obtained.
4. Results of the experiment
As shown in FIG. 1, PCR reactions were carried out using pET-22b (+) -pulF as a template and the pair of mutant primers shown in Table 1, and the PCR products were observed by electrophoresis on 1% agarose gel, and the bands marked as 2, 3, 4, 5, and 6 in FIG. 1 were the bands of mutant enzymes M485I, T487S, V496I, L528V, and G688F, respectively, and it can be seen from the electrophoresis chart of nucleic acids that the 5 pairs of mutant primers amplified a band with the expected size, but did not affect the subsequent experiments although multiple amplified bands appeared.
The protein concentration of the purified mutant enzyme was measured by BCA protein quantification kit method, the standard curve was shown in FIG. 2, and the protein concentration of the mutant enzyme was calculated according to the linear equation of the standard curve, as shown in Table 4.
TABLE 4 protein concentration of mutant enzymes
Figure BDA0002597920020000101
The results of denaturing polyacrylamide gel electrophoresis (SDS-PAGE) of the purified mutant enzyme are shown in FIG. 3. The bands numbered 2, 3, 4, 5 and 6 in FIG. 3 are the electrophoresis bands of mutant enzymes M485I, T487S, V496I, L528V and G688F, respectively, and it can be seen that Ni is in the figure2+The affinity chromatographic column plays a good role in separating and purifying the mutant enzyme, 5 mutant enzymes are presented as a single strip in gel, and the size of the mutant enzyme estimated according to the molecular weight of the protein Marker is consistent with the expectation.
Effect of pH on mutant enzyme Activity
The relative enzyme activities of 5 mutant enzymes under different pH conditions were determined separately, and the experimental results are listed in Table 5.
TABLE 5 relative enzyme Activity of mutant enzymes at different pH conditions
Figure BDA0002597920020000102
Figure BDA0002597920020000111
Note: WT means PulF which is a pullulanase
As can be seen from Table 5, when PullF is mutated to M485I, T487S, V496I, L528V and G688F, the optimum pH was changed from 5.0 to 5.5. However, compared with pullulanase PulF, 5 mutant enzymes have higher enzyme activity in a wider pH range, and particularly, the relative enzyme activity of the mutant enzymes is more than 85% in the pH range of 5.0-5.5. Under the condition of pH4.5, the relative enzyme activity of 5 mutant enzymes is obviously higher than that of Pullulan enzyme PulF. Within the pH range of 6.0-7.0, the relative enzyme activity of 5 mutant enzymes is obviously higher than that of Pullulan enzyme PulF.
In addition, the relative enzyme activity change trend of 5 mutant enzymes is greatly different from that of Pullulan enzyme PulF, but the 5 mutant enzymes have more consistent trend, the enzyme activity is slowly reduced when the pH value is far away from the optimum value, and the relative enzyme activity is more than 50% in the pH value range of 5.0-6.5. And different buffer solution systems have little influence on the enzyme activity of the buffer solutions, and the relative enzyme activity in the phosphate buffer solution with the pH value of 6.0 is closer to that in the acetic acid buffer solution with the pH value of 6.0.
Because the pH range of the pullulanase reaction in the sugar industry is 4.5-5.5, the greatest advantages of the 5 mutant enzymes compared with the pullulanase PulF are as follows by combining the analysis of the industrial application condition: the enzyme activity is higher within the range of pH5.0-5.5, and the requirement on the pH environment of reaction liquid in the saccharification process is not harsh.
Influence of temperature on the enzymatic activity of the mutants:
the relative enzyme activities of 5 mutant enzymes and pullulanase PulF at different temperatures were measured, and the experimental results are listed in Table 6.
TABLE 6 relative enzyme Activity of mutant enzymes at different temperatures
Figure BDA0002597920020000112
Figure BDA0002597920020000121
Note: WT means PulF which is a pullulanase
As can be seen from Table 6, when pullulanase PulF was mutated to M485I, T487S, V496I, L528V and G688F, the optimum temperature became 75 ℃. Within the range of 60-75 ℃, the relative enzyme activity of 5 mutant enzymes is greater than that of Pullulan enzyme PulF at the temperature.
The pullulanase in the sugar industry has the advantage that the pullulanase has higher relative enzyme activity in the temperature range of 60-75 ℃ by combining the analysis of the industrial application condition because the reaction temperature is 55-65 ℃ or even higher, wherein the most common reaction temperature is 60 ℃. However, the optimal temperature of the mutant enzymes M485I, T487S, V496I, L528V and G688F was reduced by 5 ℃ (80 ℃ → 75 ℃) compared with Pullulan enzyme, which may mean that the thermal stability of the 5 mutant enzymes is weakened.
To further explore how the thermostability of the mutant enzymes varied, the half-lives of 5 mutant enzymes were determined at 75 ℃ and 80 ℃.
Effect of temperature on mutant enzyme stability
The residual enzyme activities of the mutant enzymes M485I, T487S, V496I, L528V and G688F after incubation at 75 ℃ and 80 ℃ for different periods of time were determined, and the natural log of the residual enzyme activity was taken as the curve of the change of the residual enzyme activity with the incubation time, as shown in FIG. 4 and FIG. 5. And half-lives at two temperatures were calculated for each mutant enzyme, and the results are listed in table 7.
As is evident from FIGS. 4 and 5, the thermostability of all 5 mutant enzymes was enhanced at 75 ℃ in the order from strong to weak: L528V > G688F > V496I > T487S > M485I; the thermal stability of 5 mutant enzymes is higher than that of Pullulan enzyme at 80 ℃, and the thermal stability of the mutant enzymes is in the order from strong to weak: V496I > G688F > T487S > L528V > M485I. The sequences of the thermal stability of 5 mutant enzymes are different under the two temperature conditions.
TABLE 7 half-lives of Pullulan enzyme PulF and mutant enzymes at different temperatures
Figure BDA0002597920020000122
Figure BDA0002597920020000131
Note: WT means PulF which is a pullulanase
At 75 ℃, the half-life of M485I is improved to a minimum, but the half-life is improved by nearly 4 times compared with PulF. At 80 ℃, the half-lives of all enzymes are very short, wherein the half-life of V496I is the longest, and the half-life of M485I is the shortest.
Enzyme kinetic parameters of the mutant enzymes:
the enzyme kinetic parameters of the mutant enzymes M485I, T487S, V496I, L528V, G688F and the pullulanase PulF are listed in table 8.
TABLE 8 comparison of enzyme kinetic parameters
Figure BDA0002597920020000132
Note: WT means PulF which is a pullulanase
As can be seen from Table 8, K for 5 mutant enzymes compared to Pullulan enzyme PulFmThe values are reduced, which indicates that the combination capability of the mutant enzyme and the pullulan is enhanced; catalytic constants K of mutant enzymes M481I, V496I, L528V and G688Fcat/KmAll are increased, which shows that the catalytic efficiency of the mutant enzymes on the pullulan is improved. While embodiments of the invention have been described above, it is not limited to the applications set forth in the description and the embodiments, which are fully applicable in various fields of endeavor to which the invention pertains, and further modifications may readily be made by those skilled in the art, it being understood that the invention is not limited to the details shown and described herein without departing from the general concept defined by the appended claims and their equivalents.
Figure BDA0002597920020000141
Figure BDA0002597920020000151
Figure BDA0002597920020000161
Figure BDA0002597920020000171
Figure BDA0002597920020000181
Figure BDA0002597920020000191
Figure BDA0002597920020000201
Figure BDA0002597920020000211
Figure BDA0002597920020000221
Figure BDA0002597920020000231
Figure BDA0002597920020000241
Figure BDA0002597920020000251
Figure BDA0002597920020000261
Figure BDA0002597920020000271
Figure BDA0002597920020000281
Figure BDA0002597920020000291
Figure BDA0002597920020000301
Figure BDA0002597920020000311
Figure BDA0002597920020000321
Figure BDA0002597920020000331
Figure BDA0002597920020000341
Figure BDA0002597920020000351
Figure BDA0002597920020000361
Figure BDA0002597920020000371
Figure BDA0002597920020000381
Figure BDA0002597920020000391
Figure BDA0002597920020000401
Figure BDA0002597920020000411
Figure BDA0002597920020000421
Figure BDA0002597920020000431
Figure BDA0002597920020000441
Figure BDA0002597920020000451
Figure BDA0002597920020000461
Figure BDA0002597920020000471
Figure BDA0002597920020000481
Figure BDA0002597920020000491
Figure BDA0002597920020000501
Figure BDA0002597920020000511
Figure BDA0002597920020000521
Figure BDA0002597920020000531
SEQUENCE LISTING
<110> institute for agricultural product processing of Chinese academy of agricultural sciences
<120> mutant enzyme of heat-resistant type I pullulanase, preparation method and application thereof
<130> 1
<160> 1
<170> PatentIn version 3.5
<210> 1
<211> 820
<212> PRT
<213> Artificial sequencing
<400> 1
Met Ala Thr Glu Leu Val Ile His Tyr His Arg Trp Asp Gly Asn Tyr
1 5 10 15
Asp Gly Trp Asn Leu Trp Ile Trp Trp Val Glu Pro Ile Ser Lys Asp
20 25 30
Gly Ala Ala Tyr Gln Phe Thr Glu Lys Asp Asp Phe Gly Val Val Ala
35 40 45
Arg Val Lys Phe Asp Glu Thr Leu Thr Lys Val Gly Ile Ile Val Arg
50 55 60
Leu Asn Glu Trp Lys Glu Lys Asp Val Ala Met Asp Arg Phe Ile Ser
65 70 75 80
Ile Lys Asp Gly Lys Ala Glu Val Trp Leu Leu Gln Gly Ile Glu Gln
85 90 95
Ile Tyr Thr Thr Lys Pro Asp Thr Ser Pro Arg Val Leu Phe Ala Gln
100 105 110
Ala Arg Ala Gln Asp Val Ile Glu Ala Tyr Leu Thr Gly Gln Val Asp
115 120 125
Thr Thr Lys Val Ser Ala Lys Val Thr Val Asp Gly Val Glu Arg Lys
130 135 140
Val Ala Lys Val Glu Lys Ala Asn Pro Thr Asp Ile Ser Lys Thr Asn
145 150 155 160
His Val Lys Ile Thr Leu Ala Glu Pro Ile Lys Leu Asp Glu Val Asn
165 170 175
Lys Asp Val Gln Val Glu Ile Glu Gly Tyr Lys Pro Ala Arg Val Ile
180 185 190
Met Met Glu Ile Leu Asp Lys Ile Tyr Tyr Asp Gly Pro Leu Gly Phe
195 200 205
Glu Tyr Ser Pro Thr Lys Thr Thr Ile Arg Val Trp Ser Pro Val Ser
210 215 220
Lys Thr Val Asp Leu Leu Leu Tyr Lys Asn Trp Asp Asp Lys Glu Pro
225 230 235 240
Thr Lys Val Val Pro Met Lys Tyr Ile Gly Asn Gly Ala Trp Glu Ala
245 250 255
Val Leu Asp Gly Asp Trp Glu Gly Trp Phe Tyr Arg Ile Arg Tyr Phe
260 265 270
Ser Tyr Gly Glu Tyr Arg Glu Gly Val Asp Tyr Phe Ser Lys Ala Val
275 280 285
Thr Lys Asn Ser Ala Lys Ser Ala Ile Ile Asp Leu Lys Lys Thr Asn
290 295 300
Pro Ser Asp Trp Asp Lys Asp Val Arg Pro Thr Met Lys Ala Leu Glu
305 310 315 320
Asp Ala Ile Ile Tyr Glu Ile His Ile Ala Asp Met Thr Gly Leu Asp
325 330 335
Asn Ser Asn Val Lys Asn Lys Ala Thr Tyr Leu Gly Leu Thr Glu Lys
340 345 350
Gly Thr Arg Gly Pro Asn Gly Val Thr Thr Gly Leu Asp His Leu Val
355 360 365
Glu Leu Gly Val Thr His Val His Ile Leu Pro Met Phe Asp Phe Tyr
370 375 380
Thr Gly Asp Glu Ser Glu Arg Asp Phe Glu Lys Ser Tyr Asn Trp Gly
385 390 395 400
Tyr Asp Pro Tyr Leu Phe Thr Val Pro Glu Gly Arg Tyr Ser Thr Asn
405 410 415
Pro Ile Asp Pro His Val Arg Ile Asn Glu Val Lys Gln Met Val Lys
420 425 430
Ala Leu His Glu Asn Gly Ile Arg Val Ile Leu Asp Met Val Phe Pro
435 440 445
His Thr Phe Gly Ile Gly Val Leu Ser Pro Phe Asp Thr Ala Val Pro
450 455 460
Tyr Tyr Phe Tyr Arg Ile Asp Lys Thr Gly Ala Tyr Leu Asn Glu Ser
465 470 475 480
Gly Val Gly Asn Val Ile Ala Thr Glu Arg Pro Met Leu Arg Lys Tyr
485 490 495
Val Ile Asp Thr Leu Lys Trp Trp Val Leu Glu Tyr His Val Asp Gly
500 505 510
Phe Arg Phe Asp Gln Met Gly Leu Met Asp Lys Lys Thr Met Leu Asp
515 520 525
Leu Glu Lys Glu Leu His Ala Ile Asp Pro Thr Ile Leu Leu Tyr Gly
530 535 540
Glu Pro Trp Gly Gly Trp Gly Ala Pro Ile Arg Phe Gly Lys Ser Asp
545 550 555 560
Val Gly Gly Thr His Ile Ala Ala Phe Asn Asp Glu Phe Arg Asp Ala
565 570 575
Met Arg Gly Ser Val Phe Asn Ala Thr Val Lys Gly Phe Leu Met Gly
580 585 590
Ala Leu Ala Lys Glu Thr Ala Ile Lys Arg Gly Val Val Gly Ser Ile
595 600 605
Glu Tyr Asp Asp Val Ile Arg Ser Phe Ala Lys Asp Pro Glu Glu Thr
610 615 620
Ile Asn Tyr Val Ala Cys His Asp Asn His Thr Leu Trp Asp Lys Asn
625 630 635 640
Tyr Leu Ala Ala Gln Ala Asp Thr Asn Ile Lys Trp Thr Glu Glu Met
645 650 655
Leu Lys Asn Ala Gln Lys Leu Ala Gly Ala Ile Leu Leu Thr Ser Gln
660 665 670
Gly Ile Pro Phe Leu His Ala Gly Gln Asp Phe Ala Arg Thr Lys Lys
675 680 685
Gly Asp Glu Asn Ser Tyr Asn Ser Pro Ile Ser Ile Asn Gly Leu Asp
690 695 700
Tyr Ala Arg Lys Ala Glu Phe Ile Asp Val Phe Asn Tyr Tyr Lys Gly
705 710 715 720
Leu Ile Glu Ile Arg Lys Ala His Pro Ala Phe Arg Gln Arg Thr Ala
725 730 735
Asp Asp Ile Lys Lys Lys Ile Thr Phe Leu Pro Thr Thr Arg Lys Met
740 745 750
Val Ala Phe Thr Ile Lys Asp Glu Asn Asp Ser Trp Lys Glu Ile Leu
755 760 765
Val Ile Tyr Asn Gly Asp Thr Lys Asp Gln Asp Phe Thr Leu Pro Glu
770 775 780
Gly Thr Trp Asn Val Val Val Asp Gln Gln Asn Ala Gly Thr Lys Val
785 790 795 800
Leu Tyr Gln Val Ser Gly Lys Ile Thr Val Lys Ser Ile Ser Ala Met
805 810 815
Val Met Tyr Lys
820
<210> 2
<211> 820
<212> PRT
<213> Artificial sequencing
<400> 2
Met Ala Thr Glu Leu Val Ile His Tyr His Arg Trp Asp Gly Asn Tyr
1 5 10 15
Asp Gly Trp Asn Leu Trp Ile Trp Trp Val Glu Pro Ile Ser Lys Asp
20 25 30
Gly Ala Ala Tyr Gln Phe Thr Glu Lys Asp Asp Phe Gly Val Val Ala
35 40 45
Arg Val Lys Phe Asp Glu Thr Leu Thr Lys Val Gly Ile Ile Val Arg
50 55 60
Leu Asn Glu Trp Lys Glu Lys Asp Val Ala Met Asp Arg Phe Ile Ser
65 70 75 80
Ile Lys Asp Gly Lys Ala Glu Val Trp Leu Leu Gln Gly Ile Glu Gln
85 90 95
Ile Tyr Thr Thr Lys Pro Asp Thr Ser Pro Arg Val Leu Phe Ala Gln
100 105 110
Ala Arg Ala Gln Asp Val Ile Glu Ala Tyr Leu Thr Gly Gln Val Asp
115 120 125
Thr Thr Lys Val Ser Ala Lys Val Thr Val Asp Gly Val Glu Arg Lys
130 135 140
Val Ala Lys Val Glu Lys Ala Asn Pro Thr Asp Ile Ser Lys Thr Asn
145 150 155 160
His Val Lys Ile Thr Leu Ala Glu Pro Ile Lys Leu Asp Glu Val Asn
165 170 175
Lys Asp Val Gln Val Glu Ile Glu Gly Tyr Lys Pro Ala Arg Val Ile
180 185 190
Met Met Glu Ile Leu Asp Lys Ile Tyr Tyr Asp Gly Pro Leu Gly Phe
195 200 205
Glu Tyr Ser Pro Thr Lys Thr Thr Ile Arg Val Trp Ser Pro Val Ser
210 215 220
Lys Thr Val Asp Leu Leu Leu Tyr Lys Asn Trp Asp Asp Lys Glu Pro
225 230 235 240
Thr Lys Val Val Pro Met Lys Tyr Ile Gly Asn Gly Ala Trp Glu Ala
245 250 255
Val Leu Asp Gly Asp Trp Glu Gly Trp Phe Tyr Arg Ile Arg Tyr Phe
260 265 270
Ser Tyr Gly Glu Tyr Arg Glu Gly Val Asp Tyr Phe Ser Lys Ala Val
275 280 285
Thr Lys Asn Ser Ala Lys Ser Ala Ile Ile Asp Leu Lys Lys Thr Asn
290 295 300
Pro Ser Asp Trp Asp Lys Asp Val Arg Pro Thr Met Lys Ala Leu Glu
305 310 315 320
Asp Ala Ile Ile Tyr Glu Ile His Ile Ala Asp Met Thr Gly Leu Asp
325 330 335
Asn Ser Asn Val Lys Asn Lys Ala Thr Tyr Leu Gly Leu Thr Glu Lys
340 345 350
Gly Thr Arg Gly Pro Asn Gly Val Thr Thr Gly Leu Asp His Leu Val
355 360 365
Glu Leu Gly Val Thr His Val His Ile Leu Pro Met Phe Asp Phe Tyr
370 375 380
Thr Gly Asp Glu Ser Glu Arg Asp Phe Glu Lys Ser Tyr Asn Trp Gly
385 390 395 400
Tyr Asp Pro Tyr Leu Phe Thr Val Pro Glu Gly Arg Tyr Ser Thr Asn
405 410 415
Pro Ile Asp Pro His Val Arg Ile Asn Glu Val Lys Gln Met Val Lys
420 425 430
Ala Leu His Glu Asn Gly Ile Arg Val Ile Leu Asp Met Val Phe Pro
435 440 445
His Thr Phe Gly Ile Gly Val Leu Ser Pro Phe Asp Thr Ala Val Pro
450 455 460
Tyr Tyr Phe Tyr Arg Ile Asp Lys Thr Gly Ala Tyr Leu Asn Glu Ser
465 470 475 480
Gly Val Gly Asn Val Met Ala Ser Glu Arg Pro Met Leu Arg Lys Tyr
485 490 495
Val Ile Asp Thr Leu Lys Trp Trp Val Leu Glu Tyr His Val Asp Gly
500 505 510
Phe Arg Phe Asp Gln Met Gly Leu Met Asp Lys Lys Thr Met Leu Asp
515 520 525
Leu Glu Lys Glu Leu His Ala Ile Asp Pro Thr Ile Leu Leu Tyr Gly
530 535 540
Glu Pro Trp Gly Gly Trp Gly Ala Pro Ile Arg Phe Gly Lys Ser Asp
545 550 555 560
Val Gly Gly Thr His Ile Ala Ala Phe Asn Asp Glu Phe Arg Asp Ala
565 570 575
Met Arg Gly Ser Val Phe Asn Ala Thr Val Lys Gly Phe Leu Met Gly
580 585 590
Ala Leu Ala Lys Glu Thr Ala Ile Lys Arg Gly Val Val Gly Ser Ile
595 600 605
Glu Tyr Asp Asp Val Ile Arg Ser Phe Ala Lys Asp Pro Glu Glu Thr
610 615 620
Ile Asn Tyr Val Ala Cys His Asp Asn His Thr Leu Trp Asp Lys Asn
625 630 635 640
Tyr Leu Ala Ala Gln Ala Asp Thr Asn Ile Lys Trp Thr Glu Glu Met
645 650 655
Leu Lys Asn Ala Gln Lys Leu Ala Gly Ala Ile Leu Leu Thr Ser Gln
660 665 670
Gly Ile Pro Phe Leu His Ala Gly Gln Asp Phe Ala Arg Thr Lys Lys
675 680 685
Gly Asp Glu Asn Ser Tyr Asn Ser Pro Ile Ser Ile Asn Gly Leu Asp
690 695 700
Tyr Ala Arg Lys Ala Glu Phe Ile Asp Val Phe Asn Tyr Tyr Lys Gly
705 710 715 720
Leu Ile Glu Ile Arg Lys Ala His Pro Ala Phe Arg Gln Arg Thr Ala
725 730 735
Asp Asp Ile Lys Lys Lys Ile Thr Phe Leu Pro Thr Thr Arg Lys Met
740 745 750
Val Ala Phe Thr Ile Lys Asp Glu Asn Asp Ser Trp Lys Glu Ile Leu
755 760 765
Val Ile Tyr Asn Gly Asp Thr Lys Asp Gln Asp Phe Thr Leu Pro Glu
770 775 780
Gly Thr Trp Asn Val Val Val Asp Gln Gln Asn Ala Gly Thr Lys Val
785 790 795 800
Leu Tyr Gln Val Ser Gly Lys Ile Thr Val Lys Ser Ile Ser Ala Met
805 810 815
Val Met Tyr Lys
820
<210> 3
<211> 820
<212> PRT
<213> Artificial sequencing
<400> 3
Met Ala Thr Glu Leu Val Ile His Tyr His Arg Trp Asp Gly Asn Tyr
1 5 10 15
Asp Gly Trp Asn Leu Trp Ile Trp Trp Val Glu Pro Ile Ser Lys Asp
20 25 30
Gly Ala Ala Tyr Gln Phe Thr Glu Lys Asp Asp Phe Gly Val Val Ala
35 40 45
Arg Val Lys Phe Asp Glu Thr Leu Thr Lys Val Gly Ile Ile Val Arg
50 55 60
Leu Asn Glu Trp Lys Glu Lys Asp Val Ala Met Asp Arg Phe Ile Ser
65 70 75 80
Ile Lys Asp Gly Lys Ala Glu Val Trp Leu Leu Gln Gly Ile Glu Gln
85 90 95
Ile Tyr Thr Thr Lys Pro Asp Thr Ser Pro Arg Val Leu Phe Ala Gln
100 105 110
Ala Arg Ala Gln Asp Val Ile Glu Ala Tyr Leu Thr Gly Gln Val Asp
115 120 125
Thr Thr Lys Val Ser Ala Lys Val Thr Val Asp Gly Val Glu Arg Lys
130 135 140
Val Ala Lys Val Glu Lys Ala Asn Pro Thr Asp Ile Ser Lys Thr Asn
145 150 155 160
His Val Lys Ile Thr Leu Ala Glu Pro Ile Lys Leu Asp Glu Val Asn
165 170 175
Lys Asp Val Gln Val Glu Ile Glu Gly Tyr Lys Pro Ala Arg Val Ile
180 185 190
Met Met Glu Ile Leu Asp Lys Ile Tyr Tyr Asp Gly Pro Leu Gly Phe
195 200 205
Glu Tyr Ser Pro Thr Lys Thr Thr Ile Arg Val Trp Ser Pro Val Ser
210 215 220
Lys Thr Val Asp Leu Leu Leu Tyr Lys Asn Trp Asp Asp Lys Glu Pro
225 230 235 240
Thr Lys Val Val Pro Met Lys Tyr Ile Gly Asn Gly Ala Trp Glu Ala
245 250 255
Val Leu Asp Gly Asp Trp Glu Gly Trp Phe Tyr Arg Ile Arg Tyr Phe
260 265 270
Ser Tyr Gly Glu Tyr Arg Glu Gly Val Asp Tyr Phe Ser Lys Ala Val
275 280 285
Thr Lys Asn Ser Ala Lys Ser Ala Ile Ile Asp Leu Lys Lys Thr Asn
290 295 300
Pro Ser Asp Trp Asp Lys Asp Val Arg Pro Thr Met Lys Ala Leu Glu
305 310 315 320
Asp Ala Ile Ile Tyr Glu Ile His Ile Ala Asp Met Thr Gly Leu Asp
325 330 335
Asn Ser Asn Val Lys Asn Lys Ala Thr Tyr Leu Gly Leu Thr Glu Lys
340 345 350
Gly Thr Arg Gly Pro Asn Gly Val Thr Thr Gly Leu Asp His Leu Val
355 360 365
Glu Leu Gly Val Thr His Val His Ile Leu Pro Met Phe Asp Phe Tyr
370 375 380
Thr Gly Asp Glu Ser Glu Arg Asp Phe Glu Lys Ser Tyr Asn Trp Gly
385 390 395 400
Tyr Asp Pro Tyr Leu Phe Thr Val Pro Glu Gly Arg Tyr Ser Thr Asn
405 410 415
Pro Ile Asp Pro His Val Arg Ile Asn Glu Val Lys Gln Met Val Lys
420 425 430
Ala Leu His Glu Asn Gly Ile Arg Val Ile Leu Asp Met Val Phe Pro
435 440 445
His Thr Phe Gly Ile Gly Val Leu Ser Pro Phe Asp Thr Ala Val Pro
450 455 460
Tyr Tyr Phe Tyr Arg Ile Asp Lys Thr Gly Ala Tyr Leu Asn Glu Ser
465 470 475 480
Gly Val Gly Asn Val Met Ala Thr Glu Arg Pro Met Leu Arg Lys Tyr
485 490 495
Ile Ile Asp Thr Leu Lys Trp Trp Val Leu Glu Tyr His Val Asp Gly
500 505 510
Phe Arg Phe Asp Gln Met Gly Leu Met Asp Lys Lys Thr Met Leu Asp
515 520 525
Leu Glu Lys Glu Leu His Ala Ile Asp Pro Thr Ile Leu Leu Tyr Gly
530 535 540
Glu Pro Trp Gly Gly Trp Gly Ala Pro Ile Arg Phe Gly Lys Ser Asp
545 550 555 560
Val Gly Gly Thr His Ile Ala Ala Phe Asn Asp Glu Phe Arg Asp Ala
565 570 575
Met Arg Gly Ser Val Phe Asn Ala Thr Val Lys Gly Phe Leu Met Gly
580 585 590
Ala Leu Ala Lys Glu Thr Ala Ile Lys Arg Gly Val Val Gly Ser Ile
595 600 605
Glu Tyr Asp Asp Val Ile Arg Ser Phe Ala Lys Asp Pro Glu Glu Thr
610 615 620
Ile Asn Tyr Val Ala Cys His Asp Asn His Thr Leu Trp Asp Lys Asn
625 630 635 640
Tyr Leu Ala Ala Gln Ala Asp Thr Asn Ile Lys Trp Thr Glu Glu Met
645 650 655
Leu Lys Asn Ala Gln Lys Leu Ala Gly Ala Ile Leu Leu Thr Ser Gln
660 665 670
Gly Ile Pro Phe Leu His Ala Gly Gln Asp Phe Ala Arg Thr Lys Lys
675 680 685
Gly Asp Glu Asn Ser Tyr Asn Ser Pro Ile Ser Ile Asn Gly Leu Asp
690 695 700
Tyr Ala Arg Lys Ala Glu Phe Ile Asp Val Phe Asn Tyr Tyr Lys Gly
705 710 715 720
Leu Ile Glu Ile Arg Lys Ala His Pro Ala Phe Arg Gln Arg Thr Ala
725 730 735
Asp Asp Ile Lys Lys Lys Ile Thr Phe Leu Pro Thr Thr Arg Lys Met
740 745 750
Val Ala Phe Thr Ile Lys Asp Glu Asn Asp Ser Trp Lys Glu Ile Leu
755 760 765
Val Ile Tyr Asn Gly Asp Thr Lys Asp Gln Asp Phe Thr Leu Pro Glu
770 775 780
Gly Thr Trp Asn Val Val Val Asp Gln Gln Asn Ala Gly Thr Lys Val
785 790 795 800
Leu Tyr Gln Val Ser Gly Lys Ile Thr Val Lys Ser Ile Ser Ala Met
805 810 815
Val Met Tyr Lys
820
<210> 4
<211> 820
<212> PRT
<213> Artificial sequencing
<400> 4
Met Ala Thr Glu Leu Val Ile His Tyr His Arg Trp Asp Gly Asn Tyr
1 5 10 15
Asp Gly Trp Asn Leu Trp Ile Trp Trp Val Glu Pro Ile Ser Lys Asp
20 25 30
Gly Ala Ala Tyr Gln Phe Thr Glu Lys Asp Asp Phe Gly Val Val Ala
35 40 45
Arg Val Lys Phe Asp Glu Thr Leu Thr Lys Val Gly Ile Ile Val Arg
50 55 60
Leu Asn Glu Trp Lys Glu Lys Asp Val Ala Met Asp Arg Phe Ile Ser
65 70 75 80
Ile Lys Asp Gly Lys Ala Glu Val Trp Leu Leu Gln Gly Ile Glu Gln
85 90 95
Ile Tyr Thr Thr Lys Pro Asp Thr Ser Pro Arg Val Leu Phe Ala Gln
100 105 110
Ala Arg Ala Gln Asp Val Ile Glu Ala Tyr Leu Thr Gly Gln Val Asp
115 120 125
Thr Thr Lys Val Ser Ala Lys Val Thr Val Asp Gly Val Glu Arg Lys
130 135 140
Val Ala Lys Val Glu Lys Ala Asn Pro Thr Asp Ile Ser Lys Thr Asn
145 150 155 160
His Val Lys Ile Thr Leu Ala Glu Pro Ile Lys Leu Asp Glu Val Asn
165 170 175
Lys Asp Val Gln Val Glu Ile Glu Gly Tyr Lys Pro Ala Arg Val Ile
180 185 190
Met Met Glu Ile Leu Asp Lys Ile Tyr Tyr Asp Gly Pro Leu Gly Phe
195 200 205
Glu Tyr Ser Pro Thr Lys Thr Thr Ile Arg Val Trp Ser Pro Val Ser
210 215 220
Lys Thr Val Asp Leu Leu Leu Tyr Lys Asn Trp Asp Asp Lys Glu Pro
225 230 235 240
Thr Lys Val Val Pro Met Lys Tyr Ile Gly Asn Gly Ala Trp Glu Ala
245 250 255
Val Leu Asp Gly Asp Trp Glu Gly Trp Phe Tyr Arg Ile Arg Tyr Phe
260 265 270
Ser Tyr Gly Glu Tyr Arg Glu Gly Val Asp Tyr Phe Ser Lys Ala Val
275 280 285
Thr Lys Asn Ser Ala Lys Ser Ala Ile Ile Asp Leu Lys Lys Thr Asn
290 295 300
Pro Ser Asp Trp Asp Lys Asp Val Arg Pro Thr Met Lys Ala Leu Glu
305 310 315 320
Asp Ala Ile Ile Tyr Glu Ile His Ile Ala Asp Met Thr Gly Leu Asp
325 330 335
Asn Ser Asn Val Lys Asn Lys Ala Thr Tyr Leu Gly Leu Thr Glu Lys
340 345 350
Gly Thr Arg Gly Pro Asn Gly Val Thr Thr Gly Leu Asp His Leu Val
355 360 365
Glu Leu Gly Val Thr His Val His Ile Leu Pro Met Phe Asp Phe Tyr
370 375 380
Thr Gly Asp Glu Ser Glu Arg Asp Phe Glu Lys Ser Tyr Asn Trp Gly
385 390 395 400
Tyr Asp Pro Tyr Leu Phe Thr Val Pro Glu Gly Arg Tyr Ser Thr Asn
405 410 415
Pro Ile Asp Pro His Val Arg Ile Asn Glu Val Lys Gln Met Val Lys
420 425 430
Ala Leu His Glu Asn Gly Ile Arg Val Ile Leu Asp Met Val Phe Pro
435 440 445
His Thr Phe Gly Ile Gly Val Leu Ser Pro Phe Asp Thr Ala Val Pro
450 455 460
Tyr Tyr Phe Tyr Arg Ile Asp Lys Thr Gly Ala Tyr Leu Asn Glu Ser
465 470 475 480
Gly Val Gly Asn Val Met Ala Thr Glu Arg Pro Met Leu Arg Lys Tyr
485 490 495
Val Ile Asp Thr Leu Lys Trp Trp Val Leu Glu Tyr His Val Asp Gly
500 505 510
Phe Arg Phe Asp Gln Met Gly Leu Met Asp Lys Lys Thr Met Leu Asp
515 520 525
Val Glu Lys Glu Leu His Ala Ile Asp Pro Thr Ile Leu Leu Tyr Gly
530 535 540
Glu Pro Trp Gly Gly Trp Gly Ala Pro Ile Arg Phe Gly Lys Ser Asp
545 550 555 560
Val Gly Gly Thr His Ile Ala Ala Phe Asn Asp Glu Phe Arg Asp Ala
565 570 575
Met Arg Gly Ser Val Phe Asn Ala Thr Val Lys Gly Phe Leu Met Gly
580 585 590
Ala Leu Ala Lys Glu Thr Ala Ile Lys Arg Gly Val Val Gly Ser Ile
595 600 605
Glu Tyr Asp Asp Val Ile Arg Ser Phe Ala Lys Asp Pro Glu Glu Thr
610 615 620
Ile Asn Tyr Val Ala Cys His Asp Asn His Thr Leu Trp Asp Lys Asn
625 630 635 640
Tyr Leu Ala Ala Gln Ala Asp Thr Asn Ile Lys Trp Thr Glu Glu Met
645 650 655
Leu Lys Asn Ala Gln Lys Leu Ala Gly Ala Ile Leu Leu Thr Ser Gln
660 665 670
Gly Ile Pro Phe Leu His Ala Gly Gln Asp Phe Ala Arg Thr Lys Lys
675 680 685
Gly Asp Glu Asn Ser Tyr Asn Ser Pro Ile Ser Ile Asn Gly Leu Asp
690 695 700
Tyr Ala Arg Lys Ala Glu Phe Ile Asp Val Phe Asn Tyr Tyr Lys Gly
705 710 715 720
Leu Ile Glu Ile Arg Lys Ala His Pro Ala Phe Arg Gln Arg Thr Ala
725 730 735
Asp Asp Ile Lys Lys Lys Ile Thr Phe Leu Pro Thr Thr Arg Lys Met
740 745 750
Val Ala Phe Thr Ile Lys Asp Glu Asn Asp Ser Trp Lys Glu Ile Leu
755 760 765
Val Ile Tyr Asn Gly Asp Thr Lys Asp Gln Asp Phe Thr Leu Pro Glu
770 775 780
Gly Thr Trp Asn Val Val Val Asp Gln Gln Asn Ala Gly Thr Lys Val
785 790 795 800
Leu Tyr Gln Val Ser Gly Lys Ile Thr Val Lys Ser Ile Ser Ala Met
805 810 815
Val Met Tyr Lys
820
<210> 5
<211> 820
<212> PRT
<213> Artificial sequencing
<400> 5
Met Ala Thr Glu Leu Val Ile His Tyr His Arg Trp Asp Gly Asn Tyr
1 5 10 15
Asp Gly Trp Asn Leu Trp Ile Trp Trp Val Glu Pro Ile Ser Lys Asp
20 25 30
Gly Ala Ala Tyr Gln Phe Thr Glu Lys Asp Asp Phe Gly Val Val Ala
35 40 45
Arg Val Lys Phe Asp Glu Thr Leu Thr Lys Val Gly Ile Ile Val Arg
50 55 60
Leu Asn Glu Trp Lys Glu Lys Asp Val Ala Met Asp Arg Phe Ile Ser
65 70 75 80
Ile Lys Asp Gly Lys Ala Glu Val Trp Leu Leu Gln Gly Ile Glu Gln
85 90 95
Ile Tyr Thr Thr Lys Pro Asp Thr Ser Pro Arg Val Leu Phe Ala Gln
100 105 110
Ala Arg Ala Gln Asp Val Ile Glu Ala Tyr Leu Thr Gly Gln Val Asp
115 120 125
Thr Thr Lys Val Ser Ala Lys Val Thr Val Asp Gly Val Glu Arg Lys
130 135 140
Val Ala Lys Val Glu Lys Ala Asn Pro Thr Asp Ile Ser Lys Thr Asn
145 150 155 160
His Val Lys Ile Thr Leu Ala Glu Pro Ile Lys Leu Asp Glu Val Asn
165 170 175
Lys Asp Val Gln Val Glu Ile Glu Gly Tyr Lys Pro Ala Arg Val Ile
180 185 190
Met Met Glu Ile Leu Asp Lys Ile Tyr Tyr Asp Gly Pro Leu Gly Phe
195 200 205
Glu Tyr Ser Pro Thr Lys Thr Thr Ile Arg Val Trp Ser Pro Val Ser
210 215 220
Lys Thr Val Asp Leu Leu Leu Tyr Lys Asn Trp Asp Asp Lys Glu Pro
225 230 235 240
Thr Lys Val Val Pro Met Lys Tyr Ile Gly Asn Gly Ala Trp Glu Ala
245 250 255
Val Leu Asp Gly Asp Trp Glu Gly Trp Phe Tyr Arg Ile Arg Tyr Phe
260 265 270
Ser Tyr Gly Glu Tyr Arg Glu Gly Val Asp Tyr Phe Ser Lys Ala Val
275 280 285
Thr Lys Asn Ser Ala Lys Ser Ala Ile Ile Asp Leu Lys Lys Thr Asn
290 295 300
Pro Ser Asp Trp Asp Lys Asp Val Arg Pro Thr Met Lys Ala Leu Glu
305 310 315 320
Asp Ala Ile Ile Tyr Glu Ile His Ile Ala Asp Met Thr Gly Leu Asp
325 330 335
Asn Ser Asn Val Lys Asn Lys Ala Thr Tyr Leu Gly Leu Thr Glu Lys
340 345 350
Gly Thr Arg Gly Pro Asn Gly Val Thr Thr Gly Leu Asp His Leu Val
355 360 365
Glu Leu Gly Val Thr His Val His Ile Leu Pro Met Phe Asp Phe Tyr
370 375 380
Thr Gly Asp Glu Ser Glu Arg Asp Phe Glu Lys Ser Tyr Asn Trp Gly
385 390 395 400
Tyr Asp Pro Tyr Leu Phe Thr Val Pro Glu Gly Arg Tyr Ser Thr Asn
405 410 415
Pro Ile Asp Pro His Val Arg Ile Asn Glu Val Lys Gln Met Val Lys
420 425 430
Ala Leu His Glu Asn Gly Ile Arg Val Ile Leu Asp Met Val Phe Pro
435 440 445
His Thr Phe Gly Ile Gly Val Leu Ser Pro Phe Asp Thr Ala Val Pro
450 455 460
Tyr Tyr Phe Tyr Arg Ile Asp Lys Thr Gly Ala Tyr Leu Asn Glu Ser
465 470 475 480
Gly Val Gly Asn Val Met Ala Thr Glu Arg Pro Met Leu Arg Lys Tyr
485 490 495
Val Ile Asp Thr Leu Lys Trp Trp Val Leu Glu Tyr His Val Asp Gly
500 505 510
Phe Arg Phe Asp Gln Met Gly Leu Met Asp Lys Lys Thr Met Leu Asp
515 520 525
Leu Glu Lys Glu Leu His Ala Ile Asp Pro Thr Ile Leu Leu Tyr Gly
530 535 540
Glu Pro Trp Gly Gly Trp Gly Ala Pro Ile Arg Phe Gly Lys Ser Asp
545 550 555 560
Val Gly Gly Thr His Ile Ala Ala Phe Asn Asp Glu Phe Arg Asp Ala
565 570 575
Met Arg Gly Ser Val Phe Asn Ala Thr Val Lys Gly Phe Leu Met Gly
580 585 590
Ala Leu Ala Lys Glu Thr Ala Ile Lys Arg Gly Val Val Gly Ser Ile
595 600 605
Glu Tyr Asp Asp Val Ile Arg Ser Phe Ala Lys Asp Pro Glu Glu Thr
610 615 620
Ile Asn Tyr Val Ala Cys His Asp Asn His Thr Leu Trp Asp Lys Asn
625 630 635 640
Tyr Leu Ala Ala Gln Ala Asp Thr Asn Ile Lys Trp Thr Glu Glu Met
645 650 655
Leu Lys Asn Ala Gln Lys Leu Ala Gly Ala Ile Leu Leu Thr Ser Gln
660 665 670
Gly Ile Pro Phe Leu His Ala Gly Gln Asp Phe Ala Arg Thr Lys Lys
675 680 685
Phe Asp Glu Asn Ser Tyr Asn Ser Pro Ile Ser Ile Asn Gly Leu Asp
690 695 700
Tyr Ala Arg Lys Ala Glu Phe Ile Asp Val Phe Asn Tyr Tyr Lys Gly
705 710 715 720
Leu Ile Glu Ile Arg Lys Ala His Pro Ala Phe Arg Gln Arg Thr Ala
725 730 735
Asp Asp Ile Lys Lys Lys Ile Thr Phe Leu Pro Thr Thr Arg Lys Met
740 745 750
Val Ala Phe Thr Ile Lys Asp Glu Asn Asp Ser Trp Lys Glu Ile Leu
755 760 765
Val Ile Tyr Asn Gly Asp Thr Lys Asp Gln Asp Phe Thr Leu Pro Glu
770 775 780
Gly Thr Trp Asn Val Val Val Asp Gln Gln Asn Ala Gly Thr Lys Val
785 790 795 800
Leu Tyr Gln Val Ser Gly Lys Ile Thr Val Lys Ser Ile Ser Ala Met
805 810 815
Val Met Tyr Lys
820
<210> 6
<211> 2460
<212> DNA
<213> Artificial sequencing
<400> 6
atggcgaccg aactggtgat tcattatcat cgctgggatg gcaattatga tggctggaat 60
ctgtggattt ggtgggtgga accgattagc aaagatggcg cggcgtatca gtttaccgag 120
aaggatgatt ttggcgtggt ggcgcgcgtg aaatttgatg aaaccctgac caaagtgggc 180
attattgtgc gcctgaacga atggaaagaa aaggatgtgg cgatggatcg ctttattagc 240
atcaaagacg gcaaagcgga agtttggctg ctgcagggca ttgaacagat ttataccacc 300
aaaccggata ccagtccgcg tgtgctgttt gcacaagcgc gtgcgcaaga tgtgattgaa 360
gcgtatctga ccggccaagt ggataccacc aaagtgagcg cgaaagtgac cgtggatggc 420
gtggaacgca aagtggcgaa agtggaaaaa gcgaatccga ccgatattag caaaaccaac 480
catgtgaaaa ttaccctggc ggaaccgatt aaactggatg aggtgaacaa agatgtgcag 540
gtggaaattg aaggctataa accggcgcgc gtgattatga tggaaatcct ggacaagatt 600
tactatgatg gcccgctggg ctttgaatat agcccgacca aaaccaccat tcgcgtgtgg 660
agcccggtta gcaaaaccgt ggatctgctg ctgtataaga attgggatga taaggaaccg 720
accaaagtgg tgccgatgaa gtatattggc aatggcgcgt gggaagcagt tctggatggc 780
gattgggaag gctggtttta tcgcattcgc tactttagct atggcgaata tcgcgaaggc 840
gtggattatt ttagcaaagc ggtgaccaaa aatagcgcga aaagcgcgat tattgacctg 900
aaaaagacca atccgagcga ttgggataaa gatgtgcgcc cgaccatgaa agcgctggaa 960
gatgcgatta tctacgaaat ccacatcgcg gatatgaccg gcctggataa tagcaatgtg 1020
aaaaacaagg cgacctatct gggcctgacc gaaaaaggta cccgcggtcc gaatggtgtt 1080
accaccggcc tggatcatct ggttgaactg ggcgtgaccc atgtgcatat tctgccgatg 1140
ttcgattttt ataccggcga tgaaagcgaa cgcgattttg agaagagcta caattggggc 1200
tatgacccgt atctgtttac cgttccggaa ggccgctata gcaccaatcc gattgatccg 1260
catgtgcgca ttaatgaagt gaagcagatg gtgaaagcgc tgcatgaaaa tggcattcgc 1320
gtgattctgg atatggtgtt tccgcatacc tttggcattg gcgtgctgag cccgtttgat 1380
accgcggtgc cgtattattt ttaccgcatc gataaaaccg gcgcgtatct gaatgaaagc 1440
ggcgtgggca atgttatcgc gaccgaacgt ccgatgctgc gcaaatatgt gattgatacc 1500
ctgaaatggt gggtgctgga atatcatgtg gatggctttc gctttgatca gatgggcctg 1560
atggataaaa aaaccatgct ggacctggaa aaagaactgc atgcgattga tccgaccatt 1620
ctgctgtatg gcgaaccttg gggtggttgg ggcgcgccaa ttcgttttgg caaaagcgat 1680
gtgggcggca cccatattgc ggcgttcaat gatgaatttc gcgatgcgat gcgcggcagc 1740
gtttttaatg cgaccgtgaa aggctttctg atgggcgcgc tggcaaaaga aaccgcgatt 1800
aaacgcggtg tggtgggcag cattgaatat gatgatgtga ttcgcagctt tgcgaaagat 1860
ccggaagaga ctattaatta tgtggcgtgc catgataatc ataccctgtg ggacaaaaat 1920
tatctggcgg cgcaggcgga taccaatatt aaatggaccg aggagatgct gaaaaatgcg 1980
cagaaactgg cgggtgcgat tttgttaacc agccagggca ttccgttttt gcatgcgggc 2040
caggattttg cgcgcaccaa aaaaggcgat gagaacagct ataatagccc gattagcatt 2100
aatggcctgg attatgcgcg caaagcggaa tttatcgacg tgttcaacta ttataagggc 2160
ctgatcgaaa ttcgcaaagc gcatccggcg tttcgtcaac gtaccgcgga tgatattaag 2220
aagaagatca ccttcctgcc gaccacccgt aaaatggtgg cgttcaccat taaagatgag 2280
aacgacagct ggaaagagat cctggtgatt tataacggcg ataccaagga tcaggatttt 2340
accctgccgg aaggcacctg gaatgtggtg gtggatcagc aaaatgcggg caccaaagtg 2400
ctgtatcagg tgagcggcaa aattaccgtg aaaagcatta gcgcgatggt gatgtataaa 2460
<210> 7
<211> 2460
<212> DNA
<213> Artificial sequencing
<400> 7
atggcgaccg aactggtgat tcattatcat cgctgggatg gcaattatga tggctggaat 60
ctgtggattt ggtgggtgga accgattagc aaagatggcg cggcgtatca gtttaccgag 120
aaggatgatt ttggcgtggt ggcgcgcgtg aaatttgatg aaaccctgac caaagtgggc 180
attattgtgc gcctgaacga atggaaagaa aaggatgtgg cgatggatcg ctttattagc 240
atcaaagacg gcaaagcgga agtttggctg ctgcagggca ttgaacagat ttataccacc 300
aaaccggata ccagtccgcg tgtgctgttt gcacaagcgc gtgcgcaaga tgtgattgaa 360
gcgtatctga ccggccaagt ggataccacc aaagtgagcg cgaaagtgac cgtggatggc 420
gtggaacgca aagtggcgaa agtggaaaaa gcgaatccga ccgatattag caaaaccaac 480
catgtgaaaa ttaccctggc ggaaccgatt aaactggatg aggtgaacaa agatgtgcag 540
gtggaaattg aaggctataa accggcgcgc gtgattatga tggaaatcct ggacaagatt 600
tactatgatg gcccgctggg ctttgaatat agcccgacca aaaccaccat tcgcgtgtgg 660
agcccggtta gcaaaaccgt ggatctgctg ctgtataaga attgggatga taaggaaccg 720
accaaagtgg tgccgatgaa gtatattggc aatggcgcgt gggaagcagt tctggatggc 780
gattgggaag gctggtttta tcgcattcgc tactttagct atggcgaata tcgcgaaggc 840
gtggattatt ttagcaaagc ggtgaccaaa aatagcgcga aaagcgcgat tattgacctg 900
aaaaagacca atccgagcga ttgggataaa gatgtgcgcc cgaccatgaa agcgctggaa 960
gatgcgatta tctacgaaat ccacatcgcg gatatgaccg gcctggataa tagcaatgtg 1020
aaaaacaagg cgacctatct gggcctgacc gaaaaaggta cccgcggtcc gaatggtgtt 1080
accaccggcc tggatcatct ggttgaactg ggcgtgaccc atgtgcatat tctgccgatg 1140
ttcgattttt ataccggcga tgaaagcgaa cgcgattttg agaagagcta caattggggc 1200
tatgacccgt atctgtttac cgttccggaa ggccgctata gcaccaatcc gattgatccg 1260
catgtgcgca ttaatgaagt gaagcagatg gtgaaagcgc tgcatgaaaa tggcattcgc 1320
gtgattctgg atatggtgtt tccgcatacc tttggcattg gcgtgctgag cccgtttgat 1380
accgcggtgc cgtattattt ttaccgcatc gataaaaccg gcgcgtatct gaatgaaagc 1440
ggcgtgggca atgttatggc gagcgaacgt ccgatgctgc gcaaatatgt gattgatacc 1500
ctgaaatggt gggtgctgga atatcatgtg gatggctttc gctttgatca gatgggcctg 1560
atggataaaa aaaccatgct ggacctggaa aaagaactgc atgcgattga tccgaccatt 1620
ctgctgtatg gcgaaccttg gggtggttgg ggcgcgccaa ttcgttttgg caaaagcgat 1680
gtgggcggca cccatattgc ggcgttcaat gatgaatttc gcgatgcgat gcgcggcagc 1740
gtttttaatg cgaccgtgaa aggctttctg atgggcgcgc tggcaaaaga aaccgcgatt 1800
aaacgcggtg tggtgggcag cattgaatat gatgatgtga ttcgcagctt tgcgaaagat 1860
ccggaagaga ctattaatta tgtggcgtgc catgataatc ataccctgtg ggacaaaaat 1920
tatctggcgg cgcaggcgga taccaatatt aaatggaccg aggagatgct gaaaaatgcg 1980
cagaaactgg cgggtgcgat tttgttaacc agccagggca ttccgttttt gcatgcgggc 2040
caggattttg cgcgcaccaa aaaaggcgat gagaacagct ataatagccc gattagcatt 2100
aatggcctgg attatgcgcg caaagcggaa tttatcgacg tgttcaacta ttataagggc 2160
ctgatcgaaa ttcgcaaagc gcatccggcg tttcgtcaac gtaccgcgga tgatattaag 2220
aagaagatca ccttcctgcc gaccacccgt aaaatggtgg cgttcaccat taaagatgag 2280
aacgacagct ggaaagagat cctggtgatt tataacggcg ataccaagga tcaggatttt 2340
accctgccgg aaggcacctg gaatgtggtg gtggatcagc aaaatgcggg caccaaagtg 2400
ctgtatcagg tgagcggcaa aattaccgtg aaaagcatta gcgcgatggt gatgtataaa 2460
<210> 8
<211> 2460
<212> DNA
<213> Artificial sequencing
<400> 8
atggcgaccg aactggtgat tcattatcat cgctgggatg gcaattatga tggctggaat 60
ctgtggattt ggtgggtgga accgattagc aaagatggcg cggcgtatca gtttaccgag 120
aaggatgatt ttggcgtggt ggcgcgcgtg aaatttgatg aaaccctgac caaagtgggc 180
attattgtgc gcctgaacga atggaaagaa aaggatgtgg cgatggatcg ctttattagc 240
atcaaagacg gcaaagcgga agtttggctg ctgcagggca ttgaacagat ttataccacc 300
aaaccggata ccagtccgcg tgtgctgttt gcacaagcgc gtgcgcaaga tgtgattgaa 360
gcgtatctga ccggccaagt ggataccacc aaagtgagcg cgaaagtgac cgtggatggc 420
gtggaacgca aagtggcgaa agtggaaaaa gcgaatccga ccgatattag caaaaccaac 480
catgtgaaaa ttaccctggc ggaaccgatt aaactggatg aggtgaacaa agatgtgcag 540
gtggaaattg aaggctataa accggcgcgc gtgattatga tggaaatcct ggacaagatt 600
tactatgatg gcccgctggg ctttgaatat agcccgacca aaaccaccat tcgcgtgtgg 660
agcccggtta gcaaaaccgt ggatctgctg ctgtataaga attgggatga taaggaaccg 720
accaaagtgg tgccgatgaa gtatattggc aatggcgcgt gggaagcagt tctggatggc 780
gattgggaag gctggtttta tcgcattcgc tactttagct atggcgaata tcgcgaaggc 840
gtggattatt ttagcaaagc ggtgaccaaa aatagcgcga aaagcgcgat tattgacctg 900
aaaaagacca atccgagcga ttgggataaa gatgtgcgcc cgaccatgaa agcgctggaa 960
gatgcgatta tctacgaaat ccacatcgcg gatatgaccg gcctggataa tagcaatgtg 1020
aaaaacaagg cgacctatct gggcctgacc gaaaaaggta cccgcggtcc gaatggtgtt 1080
accaccggcc tggatcatct ggttgaactg ggcgtgaccc atgtgcatat tctgccgatg 1140
ttcgattttt ataccggcga tgaaagcgaa cgcgattttg agaagagcta caattggggc 1200
tatgacccgt atctgtttac cgttccggaa ggccgctata gcaccaatcc gattgatccg 1260
catgtgcgca ttaatgaagt gaagcagatg gtgaaagcgc tgcatgaaaa tggcattcgc 1320
gtgattctgg atatggtgtt tccgcatacc tttggcattg gcgtgctgag cccgtttgat 1380
accgcggtgc cgtattattt ttaccgcatc gataaaaccg gcgcgtatct gaatgaaagc 1440
ggcgtgggca atgttatggc gaccgaacgt ccgatgctgc gcaaatatat cattgatacc 1500
ctgaaatggt gggtgctgga atatcatgtg gatggctttc gctttgatca gatgggcctg 1560
atggataaaa aaaccatgct ggacctggaa aaagaactgc atgcgattga tccgaccatt 1620
ctgctgtatg gcgaaccttg gggtggttgg ggcgcgccaa ttcgttttgg caaaagcgat 1680
gtgggcggca cccatattgc ggcgttcaat gatgaatttc gcgatgcgat gcgcggcagc 1740
gtttttaatg cgaccgtgaa aggctttctg atgggcgcgc tggcaaaaga aaccgcgatt 1800
aaacgcggtg tggtgggcag cattgaatat gatgatgtga ttcgcagctt tgcgaaagat 1860
ccggaagaga ctattaatta tgtggcgtgc catgataatc ataccctgtg ggacaaaaat 1920
tatctggcgg cgcaggcgga taccaatatt aaatggaccg aggagatgct gaaaaatgcg 1980
cagaaactgg cgggtgcgat tttgttaacc agccagggca ttccgttttt gcatgcgggc 2040
caggattttg cgcgcaccaa aaaaggcgat gagaacagct ataatagccc gattagcatt 2100
aatggcctgg attatgcgcg caaagcggaa tttatcgacg tgttcaacta ttataagggc 2160
ctgatcgaaa ttcgcaaagc gcatccggcg tttcgtcaac gtaccgcgga tgatattaag 2220
aagaagatca ccttcctgcc gaccacccgt aaaatggtgg cgttcaccat taaagatgag 2280
aacgacagct ggaaagagat cctggtgatt tataacggcg ataccaagga tcaggatttt 2340
accctgccgg aaggcacctg gaatgtggtg gtggatcagc aaaatgcggg caccaaagtg 2400
ctgtatcagg tgagcggcaa aattaccgtg aaaagcatta gcgcgatggt gatgtataaa 2460
<210> 9
<211> 2460
<212> DNA
<213> Artificial sequencing
<400> 9
atggcgaccg aactggtgat tcattatcat cgctgggatg gcaattatga tggctggaat 60
ctgtggattt ggtgggtgga accgattagc aaagatggcg cggcgtatca gtttaccgag 120
aaggatgatt ttggcgtggt ggcgcgcgtg aaatttgatg aaaccctgac caaagtgggc 180
attattgtgc gcctgaacga atggaaagaa aaggatgtgg cgatggatcg ctttattagc 240
atcaaagacg gcaaagcgga agtttggctg ctgcagggca ttgaacagat ttataccacc 300
aaaccggata ccagtccgcg tgtgctgttt gcacaagcgc gtgcgcaaga tgtgattgaa 360
gcgtatctga ccggccaagt ggataccacc aaagtgagcg cgaaagtgac cgtggatggc 420
gtggaacgca aagtggcgaa agtggaaaaa gcgaatccga ccgatattag caaaaccaac 480
catgtgaaaa ttaccctggc ggaaccgatt aaactggatg aggtgaacaa agatgtgcag 540
gtggaaattg aaggctataa accggcgcgc gtgattatga tggaaatcct ggacaagatt 600
tactatgatg gcccgctggg ctttgaatat agcccgacca aaaccaccat tcgcgtgtgg 660
agcccggtta gcaaaaccgt ggatctgctg ctgtataaga attgggatga taaggaaccg 720
accaaagtgg tgccgatgaa gtatattggc aatggcgcgt gggaagcagt tctggatggc 780
gattgggaag gctggtttta tcgcattcgc tactttagct atggcgaata tcgcgaaggc 840
gtggattatt ttagcaaagc ggtgaccaaa aatagcgcga aaagcgcgat tattgacctg 900
aaaaagacca atccgagcga ttgggataaa gatgtgcgcc cgaccatgaa agcgctggaa 960
gatgcgatta tctacgaaat ccacatcgcg gatatgaccg gcctggataa tagcaatgtg 1020
aaaaacaagg cgacctatct gggcctgacc gaaaaaggta cccgcggtcc gaatggtgtt 1080
accaccggcc tggatcatct ggttgaactg ggcgtgaccc atgtgcatat tctgccgatg 1140
ttcgattttt ataccggcga tgaaagcgaa cgcgattttg agaagagcta caattggggc 1200
tatgacccgt atctgtttac cgttccggaa ggccgctata gcaccaatcc gattgatccg 1260
catgtgcgca ttaatgaagt gaagcagatg gtgaaagcgc tgcatgaaaa tggcattcgc 1320
gtgattctgg atatggtgtt tccgcatacc tttggcattg gcgtgctgag cccgtttgat 1380
accgcggtgc cgtattattt ttaccgcatc gataaaaccg gcgcgtatct gaatgaaagc 1440
ggcgtgggca atgttatggc gaccgaacgt ccgatgctgc gcaaatatgt gattgatacc 1500
ctgaaatggt gggtgctgga atatcatgtg gatggctttc gctttgatca gatgggcctg 1560
atggataaaa aaaccatgct ggacgtggaa aaagaactgc atgcgattga tccgaccatt 1620
ctgctgtatg gcgaaccttg gggtggttgg ggcgcgccaa ttcgttttgg caaaagcgat 1680
gtgggcggca cccatattgc ggcgttcaat gatgaatttc gcgatgcgat gcgcggcagc 1740
gtttttaatg cgaccgtgaa aggctttctg atgggcgcgc tggcaaaaga aaccgcgatt 1800
aaacgcggtg tggtgggcag cattgaatat gatgatgtga ttcgcagctt tgcgaaagat 1860
ccggaagaga ctattaatta tgtggcgtgc catgataatc ataccctgtg ggacaaaaat 1920
tatctggcgg cgcaggcgga taccaatatt aaatggaccg aggagatgct gaaaaatgcg 1980
cagaaactgg cgggtgcgat tttgttaacc agccagggca ttccgttttt gcatgcgggc 2040
caggattttg cgcgcaccaa aaaaggcgat gagaacagct ataatagccc gattagcatt 2100
aatggcctgg attatgcgcg caaagcggaa tttatcgacg tgttcaacta ttataagggc 2160
ctgatcgaaa ttcgcaaagc gcatccggcg tttcgtcaac gtaccgcgga tgatattaag 2220
aagaagatca ccttcctgcc gaccacccgt aaaatggtgg cgttcaccat taaagatgag 2280
aacgacagct ggaaagagat cctggtgatt tataacggcg ataccaagga tcaggatttt 2340
accctgccgg aaggcacctg gaatgtggtg gtggatcagc aaaatgcggg caccaaagtg 2400
ctgtatcagg tgagcggcaa aattaccgtg aaaagcatta gcgcgatggt gatgtataaa 2460
<210> 10
<211> 2460
<212> DNA
<213> Artificial sequencing
<400> 10
atggcgaccg aactggtgat tcattatcat cgctgggatg gcaattatga tggctggaat 60
ctgtggattt ggtgggtgga accgattagc aaagatggcg cggcgtatca gtttaccgag 120
aaggatgatt ttggcgtggt ggcgcgcgtg aaatttgatg aaaccctgac caaagtgggc 180
attattgtgc gcctgaacga atggaaagaa aaggatgtgg cgatggatcg ctttattagc 240
atcaaagacg gcaaagcgga agtttggctg ctgcagggca ttgaacagat ttataccacc 300
aaaccggata ccagtccgcg tgtgctgttt gcacaagcgc gtgcgcaaga tgtgattgaa 360
gcgtatctga ccggccaagt ggataccacc aaagtgagcg cgaaagtgac cgtggatggc 420
gtggaacgca aagtggcgaa agtggaaaaa gcgaatccga ccgatattag caaaaccaac 480
catgtgaaaa ttaccctggc ggaaccgatt aaactggatg aggtgaacaa agatgtgcag 540
gtggaaattg aaggctataa accggcgcgc gtgattatga tggaaatcct ggacaagatt 600
tactatgatg gcccgctggg ctttgaatat agcccgacca aaaccaccat tcgcgtgtgg 660
agcccggtta gcaaaaccgt ggatctgctg ctgtataaga attgggatga taaggaaccg 720
accaaagtgg tgccgatgaa gtatattggc aatggcgcgt gggaagcagt tctggatggc 780
gattgggaag gctggtttta tcgcattcgc tactttagct atggcgaata tcgcgaaggc 840
gtggattatt ttagcaaagc ggtgaccaaa aatagcgcga aaagcgcgat tattgacctg 900
aaaaagacca atccgagcga ttgggataaa gatgtgcgcc cgaccatgaa agcgctggaa 960
gatgcgatta tctacgaaat ccacatcgcg gatatgaccg gcctggataa tagcaatgtg 1020
aaaaacaagg cgacctatct gggcctgacc gaaaaaggta cccgcggtcc gaatggtgtt 1080
accaccggcc tggatcatct ggttgaactg ggcgtgaccc atgtgcatat tctgccgatg 1140
ttcgattttt ataccggcga tgaaagcgaa cgcgattttg agaagagcta caattggggc 1200
tatgacccgt atctgtttac cgttccggaa ggccgctata gcaccaatcc gattgatccg 1260
catgtgcgca ttaatgaagt gaagcagatg gtgaaagcgc tgcatgaaaa tggcattcgc 1320
gtgattctgg atatggtgtt tccgcatacc tttggcattg gcgtgctgag cccgtttgat 1380
accgcggtgc cgtattattt ttaccgcatc gataaaaccg gcgcgtatct gaatgaaagc 1440
ggcgtgggca atgttatggc gaccgaacgt ccgatgctgc gcaaatatgt gattgatacc 1500
ctgaaatggt gggtgctgga atatcatgtg gatggctttc gctttgatca gatgggcctg 1560
atggataaaa aaaccatgct ggacctggaa aaagaactgc atgcgattga tccgaccatt 1620
ctgctgtatg gcgaaccttg gggtggttgg ggcgcgccaa ttcgttttgg caaaagcgat 1680
gtgggcggca cccatattgc ggcgttcaat gatgaatttc gcgatgcgat gcgcggcagc 1740
gtttttaatg cgaccgtgaa aggctttctg atgggcgcgc tggcaaaaga aaccgcgatt 1800
aaacgcggtg tggtgggcag cattgaatat gatgatgtga ttcgcagctt tgcgaaagat 1860
ccggaagaga ctattaatta tgtggcgtgc catgataatc ataccctgtg ggacaaaaat 1920
tatctggcgg cgcaggcgga taccaatatt aaatggaccg aggagatgct gaaaaatgcg 1980
cagaaactgg cgggtgcgat tttgttaacc agccagggca ttccgttttt gcatgcgggc 2040
caggattttg cgcgcaccaa aaaattcgat gagaacagct ataatagccc gattagcatt 2100
aatggcctgg attatgcgcg caaagcggaa tttatcgacg tgttcaacta ttataagggc 2160
ctgatcgaaa ttcgcaaagc gcatccggcg tttcgtcaac gtaccgcgga tgatattaag 2220
aagaagatca ccttcctgcc gaccacccgt aaaatggtgg cgttcaccat taaagatgag 2280
aacgacagct ggaaagagat cctggtgatt tataacggcg ataccaagga tcaggatttt 2340
accctgccgg aaggcacctg gaatgtggtg gtggatcagc aaaatgcggg caccaaagtg 2400
ctgtatcagg tgagcggcaa aattaccgtg aaaagcatta gcgcgatggt gatgtataaa 2460
<210> 11
<211> 2460
<212> DNA
<213> Artificial sequencing
<400> 11
atggcaacag aactggtcat ccattatcat cgctgggatg gtaattacga tggttggaac 60
ctatggattt ggtgggtaga gcctatctct aaagacggcg cggcatatca atttactgaa 120
aaagatgatt tcggtgtcgt agcaagagtt aaattcgacg aaactttgac aaaagttgga 180
atcattgtta gacttaatga atggaaggaa aaagatgttg cgatggatag atttatatcg 240
ataaaagatg gaaaagcgga ggtgtggttg ttgcaaggta tcgaacagat atacacaaca 300
aagccagata caagcccaag agtacttttc gctcaagcta gagcacagga tgttatcgaa 360
gcttacttaa caggacaagt tgatactaca aaagttagcg caaaagttac agtcgacggt 420
gttgaaagaa aagttgcaaa ggttgaaaaa gcaaatccaa cggatatatc aaaaacaaac 480
cacgtaaaaa tcactcttgc tgaaccaata aagcttgacg aagtcaacaa agatgtccaa 540
gttgaaatcg aaggctacaa accagcaaga gtaatcatga tggaaatctt agacaaaata 600
tactacgatg gtccacttgg ttttgagtat tctccaacta aaactacaat cagagtatgg 660
tctcctgtct caaagacagt agatttacta ctttacaaaa attgggatga caaagaacct 720
acaaaagtcg tacctatgaa atacatcgga aatggcgcgt gggaagccgt tctcgatggt 780
gattgggaag gttggttcta tagaataaga tatttcagtt acggagagta tagggaagga 840
gtagattact tctccaaagc agtcacgaaa aactctgcaa agagcgcaat catagatctg 900
aaaaagacaa acccatctga ctgggataaa gatgtaagac caaccatgaa agctcttgaa 960
gacgctataa tctacgaaat tcatattgca gatatgacag gacttgacaa ctccaatgtc 1020
aaaaataaag ctacatacct tggccttacc gaaaagggta caagaggacc aaatggcgtt 1080
acaactggtt tagaccacct tgttgaatta ggcgttacgc atgtgcatat ccttccaatg 1140
tttgatttct acacaggtga tgaatcagaa agagattttg aaaagagcta caattgggga 1200
tacgatcctt acttattcac agtaccagaa ggtagatact caacaaaccc aattgaccca 1260
cacgttagga taaacgaagt caagcaaatg gtcaaagcat tacacgaaaa tggaataaga 1320
gtaatactcg atatggtatt cccacataca tttggtatcg gcgttctttc accatttgac 1380
acagcggtcc cttactattt ctacagaatc gataagacag gcgcttattt gaacgaaagc 1440
ggcgttggaa atgtcatggc aacagaaaga ccaatgctta gaaaatacgt tattgataca 1500
ttgaagtggt gggtattaga ataccatgtt gatggattca gattcgacca aatgggtctc 1560
atggataaga aaacaatgct agatttggaa aaagaattgc acgctataga tccaacgata 1620
ttgctctacg gtgaaccatg gggtggttgg ggtgctccaa taagattcgg aaaatcagat 1680
gttggtggaa cacacatcgc tgcatttaac gatgaattca gagacgctat gaggggttcc 1740
gtgttcaacg caacagtcaa aggtttctta atgggcgcgc ttgcaaaaga aacagcgatc 1800
aaacgtggcg ttgtcggaag cattgagtac gacgatgtaa taagaagctt tgcaaaagac 1860
ccagaagaaa caattaatta cgttgcatgc catgataacc acacactttg ggataaaaat 1920
tacttagcag ctcaagcaga tacaaacata aaatggacag aagaaatgct caaaaacgct 1980
caaaaattag ctggagccat actattaact tctcaaggta taccattctt acacgctggc 2040
caagattttg caagaaccaa aaaaggtgat gaaaattcat ataactcacc aatttcaata 2100
aacggtcttg attatgcaag aaaagcagaa ttcatagatg tcttcaatta ctacaaagga 2160
ctcatagaaa tcagaaaagc tcatccagca ttcagacaaa gaacagcaga tgatataaaa 2220
aagaaaatca catttttgcc aaccacaagg aaaatggttg cctttacaat caaagatgaa 2280
aacgatagct ggaaagagat actcgtcata tacaacggtg atacaaaaga ccaagatttt 2340
acattaccag aaggcacatg gaacgtagta gtcgaccaac aaaacgcagg tacaaaagta 2400
ttgtatcaag ttagtggaaa aataactgta aaatccatat ccgcgatggt aatgtacaag 2460
<210> 12
<211> 2460
<212> DNA
<213> Artificial sequencing
<400> 12
atggcgaccg aactggtgat tcattatcat cgctgggatg gcaattatga tggctggaat 60
ctgtggattt ggtgggtgga accgattagc aaagatggcg cggcgtatca gtttaccgag 120
aaggatgatt ttggcgtggt ggcgcgcgtg aaatttgatg aaaccctgac caaagtgggc 180
attattgtgc gcctgaacga atggaaagaa aaggatgtgg cgatggatcg ctttattagc 240
atcaaagacg gcaaagcgga agtttggctg ctgcagggca ttgaacagat ttataccacc 300
aaaccggata ccagtccgcg tgtgctgttt gcacaagcgc gtgcgcaaga tgtgattgaa 360
gcgtatctga ccggccaagt ggataccacc aaagtgagcg cgaaagtgac cgtggatggc 420
gtggaacgca aagtggcgaa agtggaaaaa gcgaatccga ccgatattag caaaaccaac 480
catgtgaaaa ttaccctggc ggaaccgatt aaactggatg aggtgaacaa agatgtgcag 540
gtggaaattg aaggctataa accggcgcgc gtgattatga tggaaatcct ggacaagatt 600
tactatgatg gcccgctggg ctttgaatat agcccgacca aaaccaccat tcgcgtgtgg 660
agcccggtta gcaaaaccgt ggatctgctg ctgtataaga attgggatga taaggaaccg 720
accaaagtgg tgccgatgaa gtatattggc aatggcgcgt gggaagcagt tctggatggc 780
gattgggaag gctggtttta tcgcattcgc tactttagct atggcgaata tcgcgaaggc 840
gtggattatt ttagcaaagc ggtgaccaaa aatagcgcga aaagcgcgat tattgacctg 900
aaaaagacca atccgagcga ttgggataaa gatgtgcgcc cgaccatgaa agcgctggaa 960
gatgcgatta tctacgaaat ccacatcgcg gatatgaccg gcctggataa tagcaatgtg 1020
aaaaacaagg cgacctatct gggcctgacc gaaaaaggta cccgcggtcc gaatggtgtt 1080
accaccggcc tggatcatct ggttgaactg ggcgtgaccc atgtgcatat tctgccgatg 1140
ttcgattttt ataccggcga tgaaagcgaa cgcgattttg agaagagcta caattggggc 1200
tatgacccgt atctgtttac cgttccggaa ggccgctata gcaccaatcc gattgatccg 1260
catgtgcgca ttaatgaagt gaagcagatg gtgaaagcgc tgcatgaaaa tggcattcgc 1320
gtgattctgg atatggtgtt tccgcatacc tttggcattg gcgtgctgag cccgtttgat 1380
accgcggtgc cgtattattt ttaccgcatc gataaaaccg gcgcgtatct gaatgaaagc 1440
ggcgtgggca atgttatggc gaccgaacgt ccgatgctgc gcaaatatgt gattgatacc 1500
ctgaaatggt gggtgctgga atatcatgtg gatggctttc gctttgatca gatgggcctg 1560
atggataaaa aaaccatgct ggacctggaa aaagaactgc atgcgattga tccgaccatt 1620
ctgctgtatg gcgaaccttg gggtggttgg ggcgcgccaa ttcgttttgg caaaagcgat 1680
gtgggcggca cccatattgc ggcgttcaat gatgaatttc gcgatgcgat gcgcggcagc 1740
gtttttaatg cgaccgtgaa aggctttctg atgggcgcgc tggcaaaaga aaccgcgatt 1800
aaacgcggtg tggtgggcag cattgaatat gatgatgtga ttcgcagctt tgcgaaagat 1860
ccggaagaga ctattaatta tgtggcgtgc catgataatc ataccctgtg ggacaaaaat 1920
tatctggcgg cgcaggcgga taccaatatt aaatggaccg aggagatgct gaaaaatgcg 1980
cagaaactgg cgggtgcgat tttgttaacc agccagggca ttccgttttt gcatgcgggc 2040
caggattttg cgcgcaccaa aaaaggcgat gagaacagct ataatagccc gattagcatt 2100
aatggcctgg attatgcgcg caaagcggaa tttatcgacg tgttcaacta ttataagggc 2160
ctgatcgaaa ttcgcaaagc gcatccggcg tttcgtcaac gtaccgcgga tgatattaag 2220
aagaagatca ccttcctgcc gaccacccgt aaaatggtgg cgttcaccat taaagatgag 2280
aacgacagct ggaaagagat cctggtgatt tataacggcg ataccaagga tcaggatttt 2340
accctgccgg aaggcacctg gaatgtggtg gtggatcagc aaaatgcggg caccaaagtg 2400
ctgtatcagg tgagcggcaa aattaccgtg aaaagcatta gcgcgatggt gatgtataaa 2460
<210> 13
<211> 820
<212> PRT
<213> Artificial sequencing
<400> 13
Met Ala Thr Glu Leu Val Ile His Tyr His Arg Trp Asp Gly Asn Tyr
1 5 10 15
Asp Gly Trp Asn Leu Trp Ile Trp Trp Val Glu Pro Ile Ser Lys Asp
20 25 30
Gly Ala Ala Tyr Gln Phe Thr Glu Lys Asp Asp Phe Gly Val Val Ala
35 40 45
Arg Val Lys Phe Asp Glu Thr Leu Thr Lys Val Gly Ile Ile Val Arg
50 55 60
Leu Asn Glu Trp Lys Glu Lys Asp Val Ala Met Asp Arg Phe Ile Ser
65 70 75 80
Ile Lys Asp Gly Lys Ala Glu Val Trp Leu Leu Gln Gly Ile Glu Gln
85 90 95
Ile Tyr Thr Thr Lys Pro Asp Thr Ser Pro Arg Val Leu Phe Ala Gln
100 105 110
Ala Arg Ala Gln Asp Val Ile Glu Ala Tyr Leu Thr Gly Gln Val Asp
115 120 125
Thr Thr Lys Val Ser Ala Lys Val Thr Val Asp Gly Val Glu Arg Lys
130 135 140
Val Ala Lys Val Glu Lys Ala Asn Pro Thr Asp Ile Ser Lys Thr Asn
145 150 155 160
His Val Lys Ile Thr Leu Ala Glu Pro Ile Lys Leu Asp Glu Val Asn
165 170 175
Lys Asp Val Gln Val Glu Ile Glu Gly Tyr Lys Pro Ala Arg Val Ile
180 185 190
Met Met Glu Ile Leu Asp Lys Ile Tyr Tyr Asp Gly Pro Leu Gly Phe
195 200 205
Glu Tyr Ser Pro Thr Lys Thr Thr Ile Arg Val Trp Ser Pro Val Ser
210 215 220
Lys Thr Val Asp Leu Leu Leu Tyr Lys Asn Trp Asp Asp Lys Glu Pro
225 230 235 240
Thr Lys Val Val Pro Met Lys Tyr Ile Gly Asn Gly Ala Trp Glu Ala
245 250 255
Val Leu Asp Gly Asp Trp Glu Gly Trp Phe Tyr Arg Ile Arg Tyr Phe
260 265 270
Ser Tyr Gly Glu Tyr Arg Glu Gly Val Asp Tyr Phe Ser Lys Ala Val
275 280 285
Thr Lys Asn Ser Ala Lys Ser Ala Ile Ile Asp Leu Lys Lys Thr Asn
290 295 300
Pro Ser Asp Trp Asp Lys Asp Val Arg Pro Thr Met Lys Ala Leu Glu
305 310 315 320
Asp Ala Ile Ile Tyr Glu Ile His Ile Ala Asp Met Thr Gly Leu Asp
325 330 335
Asn Ser Asn Val Lys Asn Lys Ala Thr Tyr Leu Gly Leu Thr Glu Lys
340 345 350
Gly Thr Arg Gly Pro Asn Gly Val Thr Thr Gly Leu Asp His Leu Val
355 360 365
Glu Leu Gly Val Thr His Val His Ile Leu Pro Met Phe Asp Phe Tyr
370 375 380
Thr Gly Asp Glu Ser Glu Arg Asp Phe Glu Lys Ser Tyr Asn Trp Gly
385 390 395 400
Tyr Asp Pro Tyr Leu Phe Thr Val Pro Glu Gly Arg Tyr Ser Thr Asn
405 410 415
Pro Ile Asp Pro His Val Arg Ile Asn Glu Val Lys Gln Met Val Lys
420 425 430
Ala Leu His Glu Asn Gly Ile Arg Val Ile Leu Asp Met Val Phe Pro
435 440 445
His Thr Phe Gly Ile Gly Val Leu Ser Pro Phe Asp Thr Ala Val Pro
450 455 460
Tyr Tyr Phe Tyr Arg Ile Asp Lys Thr Gly Ala Tyr Leu Asn Glu Ser
465 470 475 480
Gly Val Gly Asn Val Met Ala Thr Glu Arg Pro Met Leu Arg Lys Tyr
485 490 495
Val Ile Asp Thr Leu Lys Trp Trp Val Leu Glu Tyr His Val Asp Gly
500 505 510
Phe Arg Phe Asp Gln Met Gly Leu Met Asp Lys Lys Thr Met Leu Asp
515 520 525
Leu Glu Lys Glu Leu His Ala Ile Asp Pro Thr Ile Leu Leu Tyr Gly
530 535 540
Glu Pro Trp Gly Gly Trp Gly Ala Pro Ile Arg Phe Gly Lys Ser Asp
545 550 555 560
Val Gly Gly Thr His Ile Ala Ala Phe Asn Asp Glu Phe Arg Asp Ala
565 570 575
Met Arg Gly Ser Val Phe Asn Ala Thr Val Lys Gly Phe Leu Met Gly
580 585 590
Ala Leu Ala Lys Glu Thr Ala Ile Lys Arg Gly Val Val Gly Ser Ile
595 600 605
Glu Tyr Asp Asp Val Ile Arg Ser Phe Ala Lys Asp Pro Glu Glu Thr
610 615 620
Ile Asn Tyr Val Ala Cys His Asp Asn His Thr Leu Trp Asp Lys Asn
625 630 635 640
Tyr Leu Ala Ala Gln Ala Asp Thr Asn Ile Lys Trp Thr Glu Glu Met
645 650 655
Leu Lys Asn Ala Gln Lys Leu Ala Gly Ala Ile Leu Leu Thr Ser Gln
660 665 670
Gly Ile Pro Phe Leu His Ala Gly Gln Asp Phe Ala Arg Thr Lys Lys
675 680 685
Gly Asp Glu Asn Ser Tyr Asn Ser Pro Ile Ser Ile Asn Gly Leu Asp
690 695 700
Tyr Ala Arg Lys Ala Glu Phe Ile Asp Val Phe Asn Tyr Tyr Lys Gly
705 710 715 720
Leu Ile Glu Ile Arg Lys Ala His Pro Ala Phe Arg Gln Arg Thr Ala
725 730 735
Asp Asp Ile Lys Lys Lys Ile Thr Phe Leu Pro Thr Thr Arg Lys Met
740 745 750
Val Ala Phe Thr Ile Lys Asp Glu Asn Asp Ser Trp Lys Glu Ile Leu
755 760 765
Val Ile Tyr Asn Gly Asp Thr Lys Asp Gln Asp Phe Thr Leu Pro Glu
770 775 780
Gly Thr Trp Asn Val Val Val Asp Gln Gln Asn Ala Gly Thr Lys Val
785 790 795 800
Leu Tyr Gln Val Ser Gly Lys Ile Thr Val Lys Ser Ile Ser Ala Met
805 810 815
Val Met Tyr Lys
820

Claims (10)

1. The heat-resistant mutant enzyme of the pullulanase I is characterized in that the amino acid sequence of the mutant enzyme is shown as SEQ ID No. 1.
2. The gene encoding the mutant enzyme according to claim 1, wherein the nucleotide sequence of the gene encoding the mutant enzyme is represented by SEQ ID No. 6.
3. An engineered bacterium comprising a gene encoding the mutant enzyme of claim 1.
4. A vector comprising a gene encoding the mutant enzyme of claim 1.
5. A method of preparing the mutant enzyme of claim 1, comprising the steps of:
step one, taking a vector carrying a pullulanase I gene as a template, using a designed mutation primer pair, and carrying out a point mutation reaction by using a PCR mutation method to obtain a mutation plasmid with a mutant enzyme gene, wherein the pullulanase I is pullulanase PulF, the nucleotide sequence of a gene coding the pullulanase PulF is shown as SEQ ID No.11, and the mutation primer pair is respectively as follows:
f: 5'-CGGCGTGGGCAATGTTATCGCGACCGAACGT-3' and R: 5'-GATAACATTGCCCACGCCGCTTTCATTCAGATACG-3', respectively;
and step two, transforming the mutant plasmid obtained in the step one into engineering bacteria capable of expressing target genes, and expressing corresponding mutant enzymes along with the replication of the engineering bacteria.
6. The method of claim 5, wherein the point mutation reaction conditions in step one are: pre-denaturation at 94 ℃ for 5 min; melting at 94 ℃ for 20s, annealing at 65 ℃ for 20s, and extending at 72 ℃ for 4min for 25 cycles; extending for 10min at 72 ℃; keeping the temperature at 4 ℃.
7. The method of claim 5, wherein the engineered bacteria in step two is Escherichia coli.
8. The method of claim 5, wherein the vector in step one is pET-22b (+).
9. The method of claim 5, further comprising using Ni2+And (3) separating and purifying the mutant enzyme by an affinity chromatography mode.
10. Use of a mutant enzyme according to claim 1 for the preparation of a product for enzymatic hydrolysis of polysaccharides containing a-1, 6 glycosidic linkages.
CN202010715201.5A 2020-07-23 2020-07-23 Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof Active CN111808836B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010715201.5A CN111808836B (en) 2020-07-23 2020-07-23 Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010715201.5A CN111808836B (en) 2020-07-23 2020-07-23 Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN111808836A CN111808836A (en) 2020-10-23
CN111808836B true CN111808836B (en) 2021-12-07

Family

ID=72862352

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010715201.5A Active CN111808836B (en) 2020-07-23 2020-07-23 Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN111808836B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111826368B (en) * 2020-07-23 2021-11-23 中国农业科学院农产品加工研究所 Mutant enzyme of type I pullulanase and preparation method and application thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001796A2 (en) * 1998-07-02 2000-01-13 Novozymes A/S Starch debranching enzymes
AU2663801A (en) * 2000-01-12 2001-07-24 Novozymes A/S Pullulanase variants and methods for preparing such variants with predetermined properties
CN103484443B (en) * 2012-07-23 2015-12-09 江南大学 A kind of Pullulan enzymatic mutant and preparation method thereof
CN105112433A (en) * 2015-09-08 2015-12-02 广西科学院 Novel coding gene of Type-I pullulanase, and recombinant expression and application thereof
CN105200070A (en) * 2015-09-24 2015-12-30 河南仰韶生化工程有限公司 Pullulanase enzyme production gene, carrier containing same and application of carrier
CN105368805A (en) * 2015-12-16 2016-03-02 江南大学 Pullulanase mutants capable of improving heat stability and catalytic efficiency
CN105441415B (en) * 2016-01-22 2018-10-09 南宁邦尔克生物技术有限责任公司 A kind of preparation method and applications of Pullulan enzymatic mutant PulB-d99-D436H
CN106801046B (en) * 2016-09-13 2020-09-15 中国农业科学院生物技术研究所 Acid pullulanase mutant with improved thermal stability as well as encoding gene and application thereof
CN106434604A (en) * 2016-12-14 2017-02-22 曹书华 Pullulanase mutant with improved catalytic performance
BR112019018983A2 (en) * 2017-03-15 2020-04-14 Dupont Nutrition Biosci Aps methods of using an archaeal serine protease
CN108623652B (en) * 2018-03-13 2021-08-10 广西科学院 Protein thermal stability modification method and application thereof in pullulanase
CN108660145A (en) * 2018-07-05 2018-10-16 华东理工大学 The encoding gene and its recombinant expression of heat resistant type Pullulanase and application
CN109321552B (en) * 2018-10-11 2021-01-22 山东隆科特酶制剂有限公司 Novel pullulanase, gene thereof, engineering bacteria and preparation method
CN109355276B (en) * 2018-11-27 2020-08-04 江南大学 Pullulanase mutant and application thereof
CN110172468A (en) * 2019-05-10 2019-08-27 华南理工大学 One kind is from the novel Pullulanase of series bacillus and its gene and application
CN110184258B (en) * 2019-06-11 2020-11-06 南京林业大学 Pullulanase mutant
CN111235135B (en) * 2020-03-16 2021-11-02 江南大学 Neutral pullulanase mutant and application thereof

Also Published As

Publication number Publication date
CN111808836A (en) 2020-10-23

Similar Documents

Publication Publication Date Title
CN112813052B (en) Exo-inulase mutant MutDP121ET6 with improved low-temperature activity
CN111647579B (en) Thermolabile exoinulase mutant MutQ23 delta 9 and preparation and application thereof
CN112852782B (en) Low-temperature adaptive improved low Wen Waiqie inulase mutant MutDL121EK5 and application thereof
CN110066777B (en) Endo-inulase and application thereof in production of fructo-oligosaccharide
CN112725319B (en) Alginate lyase FaAly7 with polyG substrate specificity and application thereof
CN112391365B (en) Starch branching enzyme mutant with improved catalytic activity and application thereof
CN111748535B (en) Alanine dehydrogenase mutant and application thereof in fermentation production of L-alanine
CN108865962B (en) Escherichia coli engineering bacterium capable of efficiently and soluble expressing 4-alpha-glycosyltransferase
CN112301012B (en) Cyclodextrin glucosyltransferase mutant and construction method thereof
CN107384902A (en) Trehalose synthase that a kind of maltose conversion ratio improves and its preparation method and application
CN111808836B (en) Heat-resistant mutant enzyme of pullulanase I and preparation method and application thereof
CN113801240B (en) D-psicose-3-epimerase activity aggregate and preparation method and application thereof
CN113430181A (en) Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof
CN113337495A (en) Method for improving sialic acid yield and application
WO2024045796A1 (en) Cyclodextrin glucosyltransferase with improved solvent tolerance and preparation thereof
CN111826368B (en) Mutant enzyme of type I pullulanase and preparation method and application thereof
CN114736918B (en) Recombinant escherichia coli for producing salidroside by integrated expression and application thereof
CN113817704B (en) Cyclodextrin glucosyltransferase with improved organic solvent tolerance and preparation method thereof
CN113481187B (en) Algin lyase mutant and application thereof
CN115011622B (en) Screening method and application of D-psicose 3-epimerase mutant
CN111621489B (en) Thermostable inulase exonuclease mutant MutQ23 delta 6 and preparation and application thereof
CN110951716B (en) Circumscribed alginate lyase VsAly7D, recombinant strain thereof and application thereof
CN108998431B (en) A method of improving 4- alpha-glycosyl transferase Soluble expression levels
CN110804620A (en) Efficient expression and application of recombinant isoamylase for maltose production
CN112210544B (en) Cyclodextrin glucosyltransferase mutant and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant